Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1a,Condition 1b,Condition 1c,Condition 2a,Condition 2b,Condition 3,Condition 4 109,"Clark JS, et al., Hypertension 1996 Nov;28(5):898-906",arterial blood pressure trait,,RS:0000761,WKY/Gcrc,female,140 days to 137 days,6,,CMO:0000292,pulse pressure,,,continuous mean,45.9,mmHg,1.1431,2.8,MMO:0000070,intra-aortic abdominal radiotelemetry,abdominal aorta,,,,,,controlled sodium content drinking water (1 %) (between 9 and 12 days),11640,controlled sodium content drinking water (1 %) (between 9 and 12 days),,,,,, 109,"Clark JS, et al., Hypertension 1996 Nov;28(5):898-906",arterial blood pressure trait,,RS:0000761,WKY/Gcrc,male,140 days to 137 days,6,,CMO:0000292,pulse pressure,,,continuous mean,52.9,mmHg,1.5105,3.7,MMO:0000070,intra-aortic abdominal radiotelemetry,abdominal aorta,,,,,,controlled sodium content drinking water (1 %) (between 9 and 12 days),11639,controlled sodium content drinking water (1 %) (between 9 and 12 days),,,,,, 109,"Clark JS, et al., Hypertension 1996 Nov;28(5):898-906",arterial blood pressure trait,,RS:0000760,SHRSP/Gcrc,female,140 days to 137 days,6,,CMO:0000292,pulse pressure,,,continuous mean,63.8,mmHg,1.633,4.0,MMO:0000070,intra-aortic abdominal radiotelemetry,abdominal aorta,,,,,,controlled sodium content drinking water (1 %) (between 9 and 12 days),11638,controlled sodium content drinking water (1 %) (between 9 and 12 days),,,,,, 109,"Clark JS, et al., Hypertension 1996 Nov;28(5):898-906",arterial blood pressure trait,,RS:0000761,WKY/Gcrc,female,140 days to 137 days,6,,CMO:0000004,systolic blood pressure,,,continuous mean,147.1,mmHg,3.7559,9.2,MMO:0000070,intra-aortic abdominal radiotelemetry,abdominal aorta,,,,,,controlled sodium content drinking water (1 %) (between 9 and 12 days),11634,controlled sodium content drinking water (1 %) (between 9 and 12 days),,,,,, 109,"Clark JS, et al., Hypertension 1996 Nov;28(5):898-906",arterial blood pressure trait,,RS:0000761,WKY/Gcrc,male,140 days to 137 days,6,,CMO:0000004,systolic blood pressure,,,continuous mean,168.7,mmHg,2.2454,5.5,MMO:0000070,intra-aortic abdominal radiotelemetry,abdominal aorta,,,,,,controlled sodium content drinking water (1 %) (between 9 and 12 days),11633,controlled sodium content drinking water (1 %) (between 9 and 12 days),,,,,, 109,"Clark JS, et al., Hypertension 1996 Nov;28(5):898-906",arterial blood pressure trait,,RS:0000760,SHRSP/Gcrc,female,140 days to 137 days,6,,CMO:0000004,systolic blood pressure,,,continuous mean,214.3,mmHg,5.8788,14.4,MMO:0000070,intra-aortic abdominal radiotelemetry,abdominal aorta,,,,,,controlled sodium content drinking water (1 %) (between 9 and 12 days),11632,controlled sodium content drinking water (1 %) (between 9 and 12 days),,,,,, 109,"Clark JS, et al., Hypertension 1996 Nov;28(5):898-906",arterial blood pressure trait,,RS:0000761,WKY/Gcrc,female,140 days to 137 days,6,,CMO:0000005,diastolic blood pressure,,,continuous mean,101.2,mmHg,3.021,7.4,MMO:0000070,intra-aortic abdominal radiotelemetry,abdominal aorta,,,,,,controlled sodium content drinking water (1 %) (between 9 and 12 days),11637,controlled sodium content drinking water (1 %) (between 9 and 12 days),,,,,, 109,"Clark JS, et al., Hypertension 1996 Nov;28(5):898-906",arterial blood pressure trait,,RS:0000761,WKY/Gcrc,male,140 days to 137 days,6,,CMO:0000005,diastolic blood pressure,,,continuous mean,115.8,mmHg,1.7963,4.4,MMO:0000070,intra-aortic abdominal radiotelemetry,abdominal aorta,,,,,,controlled sodium content drinking water (1 %) (between 9 and 12 days),11636,controlled sodium content drinking water (1 %) (between 9 and 12 days),,,,,, 109,"Clark JS, et al., Hypertension 1996 Nov;28(5):898-906",arterial blood pressure trait,,RS:0000760,SHRSP/Gcrc,female,140 days to 137 days,6,,CMO:0000005,diastolic blood pressure,,,continuous mean,150.5,mmHg,4.4499,10.9,MMO:0000070,intra-aortic abdominal radiotelemetry,abdominal aorta,,,,,,controlled sodium content drinking water (1 %) (between 9 and 12 days),11635,controlled sodium content drinking water (1 %) (between 9 and 12 days),,,,,, 112,"Hubner N, et al., Hypertension 1999 Oct;34(4 Pt 1):643-8",arterial blood pressure trait,,RS:0001601,WKY/Bbb,not specified,124 days,11,,CMO:0000009,mean arterial blood pressure,,,,107.9,mmHg,1.2362,4.1,MMO:0000015,radiotelemetry,,0.0,,,,,controlled sodium content drinking water (1 %) (for 12 days),67208,controlled sodium content drinking water (1 %) (for 12 days),,,,,, 112,"Hubner N, et al., Hypertension 1999 Oct;34(4 Pt 1):643-8",arterial blood pressure trait,,RS:0001601,WKY/Bbb,not specified,124 days,12,,CMO:0000009,mean arterial blood pressure,,,,110.7,mmHg,0.8949,3.1,MMO:0000015,radiotelemetry,,0.0,,,,,controlled sodium content drinking water (1 %) (for 12 days),67209,controlled sodium content drinking water (1 %) (for 12 days),,,,,, 112,"Hubner N, et al., Hypertension 1999 Oct;34(4 Pt 1):643-8",arterial blood pressure trait,,RS:0001065,WKY.SHRSP-(Mt1pa-D1Rat200)/Bbb,not specified,124 days,9,,CMO:0000009,mean arterial blood pressure,,,,115.9,mmHg,1.2,3.6,MMO:0000015,radiotelemetry,,0.0,,,,,controlled sodium content drinking water (1 %) (for 12 days),67210,controlled sodium content drinking water (1 %) (for 12 days),,,,,, 112,"Hubner N, et al., Hypertension 1999 Oct;34(4 Pt 1):643-8",arterial blood pressure trait,,RS:0001066,WKY.SHRSP-(Mt1pa-D1Rat57)/Bbb,not specified,124 days,11,,CMO:0000009,mean arterial blood pressure,,,,110.9,mmHg,1.4473,4.8,MMO:0000015,radiotelemetry,,0.0,,,,,controlled sodium content drinking water (1 %) (for 12 days),67211,controlled sodium content drinking water (1 %) (for 12 days),,,,,, 112,"Hubner N, et al., Hypertension 1999 Oct;34(4 Pt 1):643-8",arterial blood pressure trait,,RS:0001065,WKY.SHRSP-(Mt1pa-D1Rat200)/Bbb,not specified,124 days,9,,CMO:0000004,systolic blood pressure,,,,138.3,mmHg,1.5333,4.6,MMO:0000015,radiotelemetry,,0.0,,,,,controlled sodium content drinking water (1 %) (for 12 days),11652,controlled sodium content drinking water (1 %) (for 12 days),,,,,, 112,"Hubner N, et al., Hypertension 1999 Oct;34(4 Pt 1):643-8",arterial blood pressure trait,,RS:0001601,WKY/Bbb,not specified,124 days,11,,CMO:0000004,systolic blood pressure,,,,129.2,mmHg,1.6583,5.5,MMO:0000015,radiotelemetry,,0.0,,,,,controlled sodium content drinking water (1 %) (for 12 days),67200,controlled sodium content drinking water (1 %) (for 12 days),,,,,, 112,"Hubner N, et al., Hypertension 1999 Oct;34(4 Pt 1):643-8",arterial blood pressure trait,,RS:0001601,WKY/Bbb,not specified,124 days,12,,CMO:0000004,systolic blood pressure,,,,134.1,mmHg,0.9815,3.4,MMO:0000015,radiotelemetry,,0.0,,,,,controlled sodium content drinking water (1 %) (for 12 days),67202,controlled sodium content drinking water (1 %) (for 12 days),,,,,, 112,"Hubner N, et al., Hypertension 1999 Oct;34(4 Pt 1):643-8",arterial blood pressure trait,,RS:0001066,WKY.SHRSP-(Mt1pa-D1Rat57)/Bbb,not specified,124 days,11,,CMO:0000004,systolic blood pressure,,,,135.2,mmHg,1.4473,4.8,MMO:0000015,radiotelemetry,,0.0,,,,,controlled sodium content drinking water (1 %) (for 12 days),67203,controlled sodium content drinking water (1 %) (for 12 days),,,,,, 112,"Hubner N, et al., Hypertension 1999 Oct;34(4 Pt 1):643-8",arterial blood pressure trait,,RS:0001601,WKY/Bbb,not specified,124 days,11,,CMO:0000005,diastolic blood pressure,,,,89.8,mmHg,1.0251,3.4,MMO:0000015,radiotelemetry,,0.0,,,,,controlled sodium content drinking water (1 %) (for 12 days),67204,controlled sodium content drinking water (1 %) (for 12 days),,,,,, 112,"Hubner N, et al., Hypertension 1999 Oct;34(4 Pt 1):643-8",arterial blood pressure trait,,RS:0001065,WKY.SHRSP-(Mt1pa-D1Rat200)/Bbb,not specified,124 days,9,,CMO:0000005,diastolic blood pressure,,,,97.4,mmHg,1.0333,3.1,MMO:0000015,radiotelemetry,,0.0,,,,,controlled sodium content drinking water (1 %) (for 12 days),67205,controlled sodium content drinking water (1 %) (for 12 days),,,,,, 112,"Hubner N, et al., Hypertension 1999 Oct;34(4 Pt 1):643-8",arterial blood pressure trait,,RS:0001601,WKY/Bbb,not specified,124 days,12,,CMO:0000005,diastolic blood pressure,,,,91.5,mmHg,0.866,3.0,MMO:0000015,radiotelemetry,,0.0,,,,,controlled sodium content drinking water (1 %) (for 12 days),67206,controlled sodium content drinking water (1 %) (for 12 days),,,,,, 112,"Hubner N, et al., Hypertension 1999 Oct;34(4 Pt 1):643-8",arterial blood pressure trait,,RS:0001066,WKY.SHRSP-(Mt1pa-D1Rat57)/Bbb,not specified,124 days,11,,CMO:0000005,diastolic blood pressure,,,,91.7,mmHg,1.4171,4.7,MMO:0000015,radiotelemetry,,0.0,,,,,controlled sodium content drinking water (1 %) (for 12 days),67207,controlled sodium content drinking water (1 %) (for 12 days),,,,,, 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",cerebrovascular system integrity trait,,RS:0000770,SHRSP/Izm,male,98 days,12,,CMO:0000932,percentage of study population developing cerebrovascular lesions during a period of time,,,,50,%,,,MMO:0000111,ex vivo light microscopy,MA:0000168,0,,,,,controlled sodium content drinking water (1 %) (for 14 days),65291,controlled sodium content drinking water (1 %) (for 14 days),,,,,, 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",cerebrovascular system integrity trait,,RS:0000770,SHRSP/Izm,female,98 days,10,,CMO:0000932,percentage of study population developing cerebrovascular lesions during a period of time,,,,0,%,,,MMO:0000111,ex vivo light microscopy,MA:0000168,0,,,,,controlled sodium content drinking water (1 %) (for 14 days),65292,controlled sodium content drinking water (1 %) (for 14 days),,,,,, 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",cerebrovascular system integrity trait,,RS:0000770,SHRSP/Izm,male,112 days,12,,CMO:0000932,percentage of study population developing cerebrovascular lesions during a period of time,,,,100,%,,,MMO:0000111,ex vivo light microscopy,MA:0000168,0,,,,,controlled sodium content drinking water (1 %) (for 28 days),65294,controlled sodium content drinking water (1 %) (for 28 days),,,,,, 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",cerebrovascular system integrity trait,,RS:0000770,SHRSP/Izm,female,112 days,10,,CMO:0000932,percentage of study population developing cerebrovascular lesions during a period of time,,,,60,%,,,MMO:0000111,ex vivo light microscopy,MA:0000168,0,,,,,controlled sodium content drinking water (1 %) (for 28 days),65295,controlled sodium content drinking water (1 %) (for 28 days),,,,,, 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",cerebrovascular system integrity trait,,RS:0000772,SHRSP.WKY-(Klk1-D1Rat116)/Izm,male,98 days,13,,CMO:0000932,percentage of study population developing cerebrovascular lesions during a period of time,,,,0,%,,,MMO:0000111,ex vivo light microscopy,MA:0000168,0,,,,,controlled sodium content drinking water (1 %) (for 14 days),65297,controlled sodium content drinking water (1 %) (for 14 days),,,,,, 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",cerebrovascular system integrity trait,,RS:0000772,SHRSP.WKY-(Klk1-D1Rat116)/Izm,female,98 days,9,,CMO:0000932,percentage of study population developing cerebrovascular lesions during a period of time,,,,0,%,,,MMO:0000111,ex vivo light microscopy,MA:0000168,0,,,,,controlled sodium content drinking water (1 %) (for 14 days),65299,controlled sodium content drinking water (1 %) (for 14 days),,,,,, 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",cerebrovascular system integrity trait,,RS:0000772,SHRSP.WKY-(Klk1-D1Rat116)/Izm,male,112 days,13,,CMO:0000932,percentage of study population developing cerebrovascular lesions during a period of time,,,,0,%,,,MMO:0000111,ex vivo light microscopy,MA:0000168,0,,,,,controlled sodium content drinking water (1 %) (for 28 days),65300,controlled sodium content drinking water (1 %) (for 28 days),,,,,, 115,"Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7.",cerebrovascular system integrity trait,,RS:0000772,SHRSP.WKY-(Klk1-D1Rat116)/Izm,male,112 days,9,,CMO:0000932,percentage of study population developing cerebrovascular lesions during a period of time,,,,0,%,,,MMO:0000111,ex vivo light microscopy,MA:0000168,0,,,,,controlled sodium content drinking water (1 %) (for 28 days),65301,controlled sodium content drinking water (1 %) (for 28 days),,,,,, 334,"Kreutz R, et al., Circulation 1997 Aug 19;96(4):1078-81.",heart pumping trait,,RS:0001601,WKY/Bbb,male,127 days to 125 days,11,,CMO:0000002,heart rate,,3 sets of readings per day for two days,serial mean,349,beats/min,12.0605,40.0,MMO:0000011,vascular indwelling catheter method,femoral artery,,,,,,controlled sodium content drinking water (1 %) (between 13 and 15 days),13286,controlled sodium content drinking water (1 %) (between 13 and 15 days),,,,,, 334,"Kreutz R, et al., Circulation 1997 Aug 19;96(4):1078-81.",heart pumping trait,,RS:0001601,WKY/Bbb,female,127 days to 125 days,10,,CMO:0000002,heart rate,,3 sets of readings per day for two days,serial mean,380,beats/min,11.068,35.0,MMO:0000011,vascular indwelling catheter method,femoral artery,,,,,,controlled sodium content drinking water (1 %) (between 13 and 15 days),13287,controlled sodium content drinking water (1 %) (between 13 and 15 days),,,,,, 334,"Kreutz R, et al., Circulation 1997 Aug 19;96(4):1078-81.",heart pumping trait,,RS:0001444,SHRSP/Bbb,male,127 days to 125 days,12,,CMO:0000002,heart rate,,3 sets of readings per day for two days,serial mean,433,beats/min,4.3301,15.0,MMO:0000011,vascular indwelling catheter method,femoral artery,,,,,,controlled sodium content drinking water (1 %) (between 13 and 15 days),13290,controlled sodium content drinking water (1 %) (between 13 and 15 days),,,,,, 334,"Kreutz R, et al., Circulation 1997 Aug 19;96(4):1078-81.",heart pumping trait,,RS:0001444,SHRSP/Bbb,female,127 days to 125 days,10,,CMO:0000002,heart rate,,3 sets of readings per day for two days,serial mean,442,beats/min,9.1706,29.0,MMO:0000011,vascular indwelling catheter method,femoral artery,,,,,,controlled sodium content drinking water (1 %) (between 13 and 15 days),13291,controlled sodium content drinking water (1 %) (between 13 and 15 days),,,,,, 281,"Monti J, et al., Hum Mol Genet 2003 Feb 15;12(4):435-9.",arterial blood pressure trait,,RS:0001601,WKY/Bbb,male,124 days to 110 days,20,,CMO:0000004,systolic blood pressure,,,,126.13,mmHg,0.55,2.4597,MMO:0000070,intra-aortic abdominal radiotelemetry,,0,,,,,controlled sodium content drinking water (1 %) (for 12 days),12654,controlled sodium content drinking water (1 %) (for 12 days),,,,,, 281,"Monti J, et al., Hum Mol Genet 2003 Feb 15;12(4):435-9.",arterial blood pressure trait,,RS:0001046,WKY.SHRSP-(D1Rat200-D1Rat216)/Bbb,male,124 days to 110 days,12,,CMO:0000004,systolic blood pressure,,,,128.65,mmHg,1.22,4.2262,MMO:0000070,intra-aortic abdominal radiotelemetry,,,,,,,controlled sodium content drinking water (1 %) (for 12 days),12657,controlled sodium content drinking water (1 %) (for 12 days),,,,,, 281,"Monti J, et al., Hum Mol Genet 2003 Feb 15;12(4):435-9.",arterial blood pressure trait,,RS:0001044,WKY.SHRSP-(Shbg-Atp1b2)/Bbb,male,124 days to 110 days,33,,CMO:0000004,systolic blood pressure,,,,129.42,mmHg,0.85,4.8829,MMO:0000070,intra-aortic abdominal radiotelemetry,,,,,,,controlled sodium content drinking water (1 %) (for 12 days),12659,controlled sodium content drinking water (1 %) (for 12 days),,,,,, 281,"Monti J, et al., Hum Mol Genet 2003 Feb 15;12(4):435-9.",arterial blood pressure trait,,RS:0001045,WKY.SHRSP-(D1Rat200-D1Rat216)(Shbg-Atp1b2)/Bbb,male,124 days to 110 days,10,,CMO:0000004,systolic blood pressure,,,,136.96,mmHg,1.91,6.04,MMO:0000070,intra-aortic abdominal radiotelemetry,,,,,,,controlled sodium content drinking water (1 %) (for 12 days),12661,controlled sodium content drinking water (1 %) (for 12 days),,,,,, 281,"Monti J, et al., Hum Mol Genet 2003 Feb 15;12(4):435-9.",arterial blood pressure trait,,RS:0001601,WKY/Bbb,male,124 days to 110 days,20,,CMO:0000005,diastolic blood pressure,,,,84.45,mmHg,0.68,3.0411,MMO:0000070,intra-aortic abdominal radiotelemetry,,0,,,,,controlled sodium content drinking water (1 %) (for 12 days),12656,controlled sodium content drinking water (1 %) (for 12 days),,,,,, 281,"Monti J, et al., Hum Mol Genet 2003 Feb 15;12(4):435-9.",arterial blood pressure trait,,RS:0001046,WKY.SHRSP-(D1Rat200-D1Rat216)/Bbb,male,124 days to 110 days,12,,CMO:0000005,diastolic blood pressure,,,,92.94,mmHg,1.11,3.8452,MMO:0000070,intra-aortic abdominal radiotelemetry,,,,,,,controlled sodium content drinking water (1 %) (for 12 days),12658,controlled sodium content drinking water (1 %) (for 12 days),,,,,, 281,"Monti J, et al., Hum Mol Genet 2003 Feb 15;12(4):435-9.",arterial blood pressure trait,,RS:0001044,WKY.SHRSP-(Shbg-Atp1b2)/Bbb,male,124 days to 110 days,33,,CMO:0000005,diastolic blood pressure,,,,91.08,mmHg,0.87,4.9978,MMO:0000070,intra-aortic abdominal radiotelemetry,,,,,,,controlled sodium content drinking water (1 %) (for 12 days),12660,controlled sodium content drinking water (1 %) (for 12 days),,,,,, 281,"Monti J, et al., Hum Mol Genet 2003 Feb 15;12(4):435-9.",arterial blood pressure trait,,RS:0001045,WKY.SHRSP-(D1Rat200-D1Rat216)(Shbg-Atp1b2)/Bbb,male,124 days to 110 days,10,,CMO:0000005,diastolic blood pressure,,,,96.86,mmHg,1.09,3.4469,MMO:0000070,intra-aortic abdominal radiotelemetry,,,,,,,controlled sodium content drinking water (1 %) (for 12 days),12662,controlled sodium content drinking water (1 %) (for 12 days),,,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0000677,SBH/Ygl,male,0 days,13,,CMO:0000004,systolic blood pressure,,,serial mean,197,mmHg,1.0,3.6056,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12236,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0000677,SBH/Ygl,female,0 days,14,,CMO:0000004,systolic blood pressure,,,serial mean,194,mmHg,1.0,3.7417,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12237,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0000679,SBN/Ygl,male,0 days,13,,CMO:0000004,systolic blood pressure,,,serial mean,128,mmHg,1.0,3.6056,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12240,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0000679,SBN/Ygl,female,0 days,14,,CMO:0000004,systolic blood pressure,,,serial mean,126,mmHg,1.0,3.7417,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12241,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002110,SBH.SBN-(D1Mgh2-D1Rat101)/Ygl,male,0 days,7,,CMO:0000004,systolic blood pressure,,,serial mean,181,mmHg,7.0,18.5203,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12244,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002110,SBH.SBN-(D1Mgh2-D1Rat101)/Ygl,female,0 days,11,,CMO:0000004,systolic blood pressure,,,serial mean,178,mmHg,4.0,13.2665,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12245,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002114,SBH.SBN-(D1Wox11-D1Rat137)/Ygl,male,0 days,9,,CMO:0000004,systolic blood pressure,,,serial mean,172,mmHg,7.0,21.0,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12248,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002114,SBH.SBN-(D1Wox11-D1Rat137)/Ygl,female,0 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,162,mmHg,6.0,14.6969,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12249,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002113,SBH.SBN-(D1Rat137-D1Rat83)/Ygl,male,0 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,167,mmHg,4.0,9.798,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12253,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002113,SBH.SBN-(D1Rat137-D1Rat83)/Ygl,female,0 days,7,,CMO:0000004,systolic blood pressure,,,serial mean,173,mmHg,3.0,7.9373,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12256,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002112,SBH.SBN-(D1Rat137-D1Rat123)/Ygl,male,0 days,9,,CMO:0000004,systolic blood pressure,,,serial mean,169,mmHg,8.0,24.0,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12264,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002112,SBH.SBN-(D1Rat137-D1Rat123)/Ygl,female,0 days,9,,CMO:0000004,systolic blood pressure,,,serial mean,162,mmHg,6.0,18.0,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12265,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002108,SBH.SBN-(D1Mgh2-D1Mgh11)/Ygl,male,0 days,13,,CMO:0000004,systolic blood pressure,,,serial mean,163,mmHg,5.0,18.0278,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12268,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002108,SBH.SBN-(D1Mgh2-D1Mgh11)/Ygl,female,0 days,16,,CMO:0000004,systolic blood pressure,,,serial mean,156,mmHg,3.0,12.0,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12269,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002111,SBH.SBN-(D1Mgh2-D1Rat74)/Ygl,male,0 days,14,,CMO:0000004,systolic blood pressure,,,serial mean,158,mmHg,4.0,14.9666,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12272,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002111,SBH.SBN-(D1Mgh2-D1Rat74)/Ygl,female,0 days,13,,CMO:0000004,systolic blood pressure,,,serial mean,154,mmHg,5.0,18.0278,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12273,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002119,SBN.SBH-(D1Rat27-D1Mit7)/Ygl,male,0 days,10,,CMO:0000004,systolic blood pressure,,,serial mean,132,mmHg,2.0,6.3246,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12280,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002119,SBN.SBH-(D1Rat27-D1Mit7)/Ygl,female,0 days,5,,CMO:0000004,systolic blood pressure,,,serial mean,130,mmHg,1.0,2.2361,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12289,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002117,SBN.SBH-(D1Rat101-D1Rat74)/Ygl,male,0 days,7,,CMO:0000004,systolic blood pressure,,,serial mean,131,mmHg,1.0,2.6458,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12293,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002117,SBN.SBH-(D1Rat101-D1Rat74)/Ygl,female,0 days,8,,CMO:0000004,systolic blood pressure,,,serial mean,128,mmHg,1.0,2.8284,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12294,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002116,SBN.SBH-(D1Mgh17-D1Mgh14)/Ygl,male,0 days,11,,CMO:0000004,systolic blood pressure,,,serial mean,130,mmHg,1.0,3.3166,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12300,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002116,SBN.SBH-(D1Mgh17-D1Mgh14)/Ygl,female,0 days,8,,CMO:0000004,systolic blood pressure,,,serial mean,128,mmHg,1.0,2.8284,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12301,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002118,SBN.SBH-(D1Rat148-D1Rat89)/Ygl,male,0 days,12,,CMO:0000004,systolic blood pressure,,,serial mean,130,mmHg,1.0,3.4641,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12306,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,, 236,"Yagil C, et al., Physiol Genomics 2003 Jan 15;12(2):85-95.",arterial blood pressure trait,,RS:0002118,SBN.SBH-(D1Rat148-D1Rat89)/Ygl,female,0 days,8,,CMO:0000004,systolic blood pressure,,,serial mean,128,mmHg,1.0,2.8284,MMO:0000052,tail cuff photoplethysmography,,172800,"photoelectric oscillatory detection device (IITC Life Science, Woodland Hills, CA)",,,,controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),12308,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),,,,, 302,"Graham D, et al., Hypertension. 2007 Dec; 50(6):1134-41.",arterial blood pressure trait,,RS:0000761,WKY/Gcrc,male,147 days to 126 days,10,,CMO:0000004,systolic blood pressure,,averaged over 21 days,,146.4,mmHg,2.53,8.0006,MMO:0000011,vascular indwelling catheter method,abdominal aorta,1814400,implanted at 84 days with 7 day recovery; Dataquest IV telemetry system (Data Sciences International),,,,controlled sodium content drinking water (1 %) (for 21 days),12727,controlled sodium content drinking water (1 %) (for 21 days),,,,,, 302,"Graham D, et al., Hypertension. 2007 Dec; 50(6):1134-41.",arterial blood pressure trait,,RS:0000760,SHRSP/Gcrc,male,147 days to 126 days,13,,CMO:0000004,systolic blood pressure,,averaged over 21 days,,225.2,mmHg,5.27,19.0013,MMO:0000013,vascular fluid filled catheter,abdominal aorta,1814400,implanted at 84 days with 7 day recovery; Dataquest IV telemetry system (Data Sciences International),,,,controlled sodium content drinking water (1 %) (for 21 days),12729,controlled sodium content drinking water (1 %) (for 21 days),,,,,, 302,"Graham D, et al., Hypertension. 2007 Dec; 50(6):1134-41.",arterial blood pressure trait,,RS:0000763,SHRSP.WKY-(D2Rat13-D2Rat157)/Gcrc,male,147 days to 126 days,8,,CMO:0000004,systolic blood pressure,,averaged over 21 days,,189.6,mmHg,3.43,9.7015,MMO:0000013,vascular fluid filled catheter,abdominal aorta,1814400,implanted at 84 days with 7 day recovery; Dataquest IV telemetry system (Data Sciences International),,,,controlled sodium content drinking water (1 %) (for 21 days),12731,controlled sodium content drinking water (1 %) (for 21 days),,,,,, 302,"Graham D, et al., Hypertension. 2007 Dec; 50(6):1134-41.",arterial blood pressure trait,,RS:0001653,SHRSP.WKY-(D2Mit21-D2Rat157)/Gcrc,male,147 days to 126 days,7,,CMO:0000004,systolic blood pressure,,averaged over 21 days,,195.9,mmHg,1.53,4.048,MMO:0000013,vascular fluid filled catheter,abdominal aorta,1814400,implanted at 84 days with 7 day recovery; Dataquest IV telemetry system (Data Sciences International),,,,controlled sodium content drinking water (1 %) (for 21 days),12733,controlled sodium content drinking water (1 %) (for 21 days),,,,,, 302,"Graham D, et al., Hypertension. 2007 Dec; 50(6):1134-41.",arterial blood pressure trait,,RS:0000768,SHRSP.WKY-(D2Wox9-D2Mgh12)/Gcrc,male,147 days to 126 days,12,,CMO:0000004,systolic blood pressure,,averaged over 21 days,,218.2,mmHg,7.28,25.2187,MMO:0000013,vascular fluid filled catheter,abdominal aorta,1814400,implanted at 84 days with 7 day recovery; Dataquest IV telemetry system (Data Sciences International),,,,controlled sodium content drinking water (1 %) (for 21 days),12735,controlled sodium content drinking water (1 %) (for 21 days),,,,,, 306,"Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6.",arterial blood pressure trait,,RS:0002154,SHR.BN-(D2Rat114-D2Rat123)/Jk,male,99 days,23,,CMO:0000009,mean arterial blood pressure,,,continuous mean,156,mmHg,3.0,14.3875,MMO:0000011,vascular indwelling catheter method,femoral artery,1800,"pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH)",,,,controlled sodium content drinking water (1 %) (for 15 days),65344,controlled sodium content drinking water (1 %) (for 15 days),,,,,, 306,"Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6.",arterial blood pressure trait,,RS:0000015,SHR,male,99 days,24,,CMO:0000009,mean arterial blood pressure,,,continuous mean,170,mmHg,3.0,14.6969,MMO:0000011,vascular indwelling catheter method,femoral artery,1800,"pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH)",,,,controlled sodium content drinking water (1 %) (for 15 days),65348,controlled sodium content drinking water (1 %) (for 15 days),,,,,, 306,"Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6.",arterial blood pressure trait,,RS:0002155,SHR.BN-(D2Rat226-D2Rat294)/Jk,male,99 days,22,,CMO:0000009,mean arterial blood pressure,,,continuous mean,154,mmHg,2.0,9.3808,MMO:0000011,vascular indwelling catheter method,femoral artery,1800,"pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH)",,,,controlled sodium content drinking water (1 %) (for 15 days),65403,controlled sodium content drinking water (1 %) (for 15 days),,,,,, 306,"Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6.",arterial blood pressure trait,,RS:0002156,SHR.BN-(D4Rat33-D4Rat54)/Jk,male,99 days,23,,CMO:0000009,mean arterial blood pressure,,,continuous mean,162,mmHg,2.0,9.5917,MMO:0000011,vascular indwelling catheter method,femoral artery,1800,"pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH)",,,,controlled sodium content drinking water (1 %) (for 15 days),65409,controlled sodium content drinking water (1 %) (for 15 days),,,,,, 306,"Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6.",arterial blood pressure trait,,RS:0002147,SHR.BN-(D16Rat87-D16Mgh1)/Jk,male,99 days,23,,CMO:0000009,mean arterial blood pressure,,,continuous mean,154,mmHg,3.0,14.3875,MMO:0000011,vascular indwelling catheter method,femoral artery,1800,"pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH)",,,,controlled sodium content drinking water (1 %) (for 15 days),65415,controlled sodium content drinking water (1 %) (for 15 days),,,,,, 306,"Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6.",arterial blood pressure trait,,RS:0000015,SHR,male,99 days,24,,CMO:0000004,systolic blood pressure,,,continuous mean,196.6,mmHg,3.2,15.6767,MMO:0000011,vascular indwelling catheter method,femoral artery,1800,"pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH)",,,,controlled sodium content drinking water (1 %) (for 15 days),12749,controlled sodium content drinking water (1 %) (for 15 days),,,,,, 306,"Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6.",arterial blood pressure trait,,RS:0002154,SHR.BN-(D2Rat114-D2Rat123)/Jk,male,99 days,23,,CMO:0000004,systolic blood pressure,,,continuous mean,179.3,mmHg,3.5,16.7854,MMO:0000011,vascular indwelling catheter method,femoral artery,1800,"pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH)",,,,controlled sodium content drinking water (1 %) (for 15 days),12750,controlled sodium content drinking water (1 %) (for 15 days),,,,,, 306,"Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6.",arterial blood pressure trait,,RS:0002155,SHR.BN-(D2Rat226-D2Rat294)/Jk,male,99 days,22,,CMO:0000004,systolic blood pressure,,,continuous mean,177.6,mmHg,2.0,9.3808,MMO:0000011,vascular indwelling catheter method,femoral artery,1800,"pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH)",,,,controlled sodium content drinking water (1 %) (for 15 days),12751,controlled sodium content drinking water (1 %) (for 15 days),,,,,, 306,"Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6.",arterial blood pressure trait,,RS:0002156,SHR.BN-(D4Rat33-D4Rat54)/Jk,male,99 days,23,,CMO:0000004,systolic blood pressure,,,continuous mean,188.7,mmHg,2.4,11.51,MMO:0000011,vascular indwelling catheter method,femoral artery,1800,"pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH)",,,,controlled sodium content drinking water (1 %) (for 15 days),12752,controlled sodium content drinking water (1 %) (for 15 days),,,,,, 306,"Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6.",arterial blood pressure trait,,RS:0002147,SHR.BN-(D16Rat87-D16Mgh1)/Jk,male,99 days,23,,CMO:0000004,systolic blood pressure,,,continuous mean,178.5,mmHg,2.7,12.9487,MMO:0000011,vascular indwelling catheter method,femoral artery,1800,"pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH)",,,,controlled sodium content drinking water (1 %) (for 15 days),12753,controlled sodium content drinking water (1 %) (for 15 days),,,,,, 306,"Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6.",arterial blood pressure trait,,RS:0000113,BN,male,99 days,64,,CMO:0000004,systolic blood pressure,,,continuous mean,134.4,mmHg,8.7,69.6,MMO:0000011,vascular indwelling catheter method,femoral artery,1800,"pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH)",,,,controlled sodium content drinking water (1 %) (for 15 days),65342,controlled sodium content drinking water (1 %) (for 15 days),,,,,, 306,"Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6.",arterial blood pressure trait,,RS:0002154,SHR.BN-(D2Rat114-D2Rat123)/Jk,male,99 days,23,,CMO:0000005,diastolic blood pressure,,,continuous mean,133,mmHg,2.0,9.5917,MMO:0000011,vascular indwelling catheter method,femoral artery,1800,"pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH)",,,,controlled sodium content drinking water (1 %) (for 15 days),65343,controlled sodium content drinking water (1 %) (for 15 days),,,,,, 306,"Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6.",arterial blood pressure trait,,RS:0000015,SHR,male,99 days,24,,CMO:0000005,diastolic blood pressure,,,continuous mean,144,mmHg,2.0,9.798,MMO:0000011,vascular indwelling catheter method,femoral artery,1800,"pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH)",,,,controlled sodium content drinking water (1 %) (for 15 days),65349,controlled sodium content drinking water (1 %) (for 15 days),,,,,, 306,"Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6.",arterial blood pressure trait,,RS:0002155,SHR.BN-(D2Rat226-D2Rat294)/Jk,male,99 days,22,,CMO:0000005,diastolic blood pressure,,,continuous mean,131,mmHg,2.0,9.3808,MMO:0000011,vascular indwelling catheter method,femoral artery,1800,"pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH)",,,,controlled sodium content drinking water (1 %) (for 15 days),65402,controlled sodium content drinking water (1 %) (for 15 days),,,,,, 306,"Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6.",arterial blood pressure trait,,RS:0002156,SHR.BN-(D4Rat33-D4Rat54)/Jk,male,99 days,23,,CMO:0000005,diastolic blood pressure,,,continuous mean,136,mmHg,2.0,9.5917,MMO:0000011,vascular indwelling catheter method,femoral artery,1800,"pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH)",,,,controlled sodium content drinking water (1 %) (for 15 days),65408,controlled sodium content drinking water (1 %) (for 15 days),,,,,, 306,"Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6.",arterial blood pressure trait,,RS:0002147,SHR.BN-(D16Rat87-D16Mgh1)/Jk,male,99 days,23,,CMO:0000005,diastolic blood pressure,,,continuous mean,130,mmHg,3.0,14.3875,MMO:0000011,vascular indwelling catheter method,femoral artery,1800,"pressure transducer (P23Dd; Stathan, Hato Rey, Puerto Rico), amplifier (GPA-4 model 2; Stemtech, Wood Dale, IL), 10-bit analog-to- digital converter (DataQ Instruments, Akron, OH)",,,,controlled sodium content drinking water (1 %) (for 15 days),65414,controlled sodium content drinking water (1 %) (for 15 days),,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000760,SHRSP/Gcrc,male,147 days to 126 days,3,,CMO:0000009,mean arterial blood pressure,,,continuous mean,171.2,mmHg,5.3,9.1799,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65658,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000760,SHRSP/Gcrc,male,147 days to 126 days,3,,CMO:0000009,mean arterial blood pressure,,,continuous mean,188.1,mmHg,5.9,10.2191,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65659,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000760,SHRSP/Gcrc,female,147 days to 126 days,3,,CMO:0000009,mean arterial blood pressure,,,continuous mean,139,mmHg,3.4,5.889,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65660,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000760,SHRSP/Gcrc,female,147 days to 126 days,3,,CMO:0000009,mean arterial blood pressure,,,continuous mean,151.6,mmHg,3.9,6.755,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65661,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000761,WKY/Gcrc,male,147 days to 126 days,4,,CMO:0000009,mean arterial blood pressure,,,continuous mean,110,mmHg,7.0,14.0,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65670,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000761,WKY/Gcrc,male,147 days to 126 days,4,,CMO:0000009,mean arterial blood pressure,,,continuous mean,117.7,mmHg,7.5,15.0,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65671,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000761,WKY/Gcrc,female,147 days to 126 days,3,,CMO:0000009,mean arterial blood pressure,,,continuous mean,105.2,mmHg,2.9,5.0229,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65672,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000761,WKY/Gcrc,female,147 days to 126 days,3,,CMO:0000009,mean arterial blood pressure,,,continuous mean,112.2,mmHg,2.7,4.6765,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65673,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000763,SHRSP.WKY-(D2Rat13-D2Rat157)/Gcrc,male,147 days to 126 days,3,,CMO:0000009,mean arterial blood pressure,,,continuous mean,147.8,mmHg,4.3,7.4478,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65682,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000760,SHRSP/Gcrc,male,147 days to 126 days,3,,CMO:0000009,mean arterial blood pressure,,,continuous mean,156.4,mmHg,6.5,11.2583,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65683,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000763,SHRSP.WKY-(D2Rat13-D2Rat157)/Gcrc,female,147 days to 126 days,3,,CMO:0000009,mean arterial blood pressure,,,continuous mean,123.9,mmHg,3.6,6.2354,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65684,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000763,SHRSP.WKY-(D2Rat13-D2Rat157)/Gcrc,female,147 days to 126 days,3,,CMO:0000009,mean arterial blood pressure,,,continuous mean,130.8,mmHg,4.8,8.3138,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65685,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000764,SHRSP.WKY-(D2Rat13-D2Mit5)/Gcrc,male,147 days to 126 days,3,,CMO:0000009,mean arterial blood pressure,,,continuous mean,163.5,mmHg,12.2,21.131,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65694,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000764,SHRSP.WKY-(D2Rat13-D2Mit5)/Gcrc,male,147 days to 126 days,3,,CMO:0000009,mean arterial blood pressure,,,continuous mean,178.3,mmHg,13.0,22.5167,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65695,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000764,SHRSP.WKY-(D2Rat13-D2Mit5)/Gcrc,female,147 days to 126 days,3,,CMO:0000009,mean arterial blood pressure,,,continuous mean,134.1,mmHg,4.2,7.2746,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65696,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000764,SHRSP.WKY-(D2Rat13-D2Mit5)/Gcrc,female,147 days to 126 days,3,,CMO:0000009,mean arterial blood pressure,,,continuous mean,144.2,mmHg,4.5,7.7942,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65697,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0001059,WKY.SHRSP-(D2Mit5-D2Mgh12)/Gcrc,male,147 days to 126 days,3,,CMO:0000009,mean arterial blood pressure,,,continuous mean,126.6,mmHg,4.8,8.3138,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65706,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0001059,WKY.SHRSP-(D2Mit5-D2Mgh12)/Gcrc,male,147 days to 126 days,3,,CMO:0000009,mean arterial blood pressure,,,continuous mean,133.1,mmHg,4.8,8.3138,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65707,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0001059,WKY.SHRSP-(D2Mit5-D2Mgh12)/Gcrc,female,147 days to 126 days,3,,CMO:0000009,mean arterial blood pressure,,,continuous mean,112.1,mmHg,7.2,12.4708,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65708,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0001059,WKY.SHRSP-(D2Mit5-D2Mgh12)/Gcrc,female,147 days to 126 days,3,,CMO:0000009,mean arterial blood pressure,,,continuous mean,120,mmHg,6.6,11.4315,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65709,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0001062,WKY.SHRSP-(Fst-Pklr)/Gcrc,male,147 days to 126 days,3,,CMO:0000009,mean arterial blood pressure,,,continuous mean,115,mmHg,1.5,2.5981,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65718,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0001062,WKY.SHRSP-(Fst-Pklr)/Gcrc,male,147 days to 126 days,3,,CMO:0000009,mean arterial blood pressure,,,continuous mean,124.3,mmHg,1.6,2.7713,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65719,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0001062,WKY.SHRSP-(Fst-Pklr)/Gcrc,female,147 days to 126 days,3,,CMO:0000009,mean arterial blood pressure,,,continuous mean,95.6,mmHg,7.1,12.2976,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65720,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0001062,WKY.SHRSP-(Fst-Pklr)/Gcrc,female,147 days to 126 days,3,,CMO:0000009,mean arterial blood pressure,,,continuous mean,104.8,mmHg,7.5,12.9904,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65721,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000760,SHRSP/Gcrc,male,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,207.9,mmHg,5.5,9.5263,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65650,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000760,SHRSP/Gcrc,male,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,229.8,mmHg,7.3,12.644,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65651,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000760,SHRSP/Gcrc,female,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,173.4,mmHg,3.9,6.755,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65652,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000760,SHRSP/Gcrc,female,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,185.5,mmHg,4.5,7.7942,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65653,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000761,WKY/Gcrc,male,147 days to 126 days,4,,CMO:0000004,systolic blood pressure,,,continuous mean,136.6,mmHg,8.2,16.4,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65662,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000761,WKY/Gcrc,male,147 days to 126 days,4,,CMO:0000004,systolic blood pressure,,,continuous mean,144.2,mmHg,8.8,17.6,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65663,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000761,WKY/Gcrc,female,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,131.7,mmHg,3.2,5.5426,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65664,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000761,WKY/Gcrc,female,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,138.9,mmHg,2.6,4.5033,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65665,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000763,SHRSP.WKY-(D2Rat13-D2Rat157)/Gcrc,male,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,180.7,mmHg,2.5,4.3301,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65674,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000763,SHRSP.WKY-(D2Rat13-D2Rat157)/Gcrc,male,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,191.2,mmHg,3.4,5.889,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65675,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000763,SHRSP.WKY-(D2Rat13-D2Rat157)/Gcrc,female,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,154.9,mmHg,3.7,6.4086,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65676,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000763,SHRSP.WKY-(D2Rat13-D2Rat157)/Gcrc,female,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,161.6,mmHg,5.4,9.3531,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65677,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000764,SHRSP.WKY-(D2Rat13-D2Mit5)/Gcrc,male,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,202.1,mmHg,12.4,21.4774,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65686,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000764,SHRSP.WKY-(D2Rat13-D2Mit5)/Gcrc,male,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,221.3,mmHg,15.4,26.6736,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65687,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000764,SHRSP.WKY-(D2Rat13-D2Mit5)/Gcrc,female,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,167.6,mmHg,5.5,9.5263,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65688,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000764,SHRSP.WKY-(D2Rat13-D2Mit5)/Gcrc,female,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,176.8,mmHg,6.3,10.9119,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65689,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0001059,WKY.SHRSP-(D2Mit5-D2Mgh12)/Gcrc,male,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,155.8,mmHg,3.7,6.4086,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65698,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0001059,WKY.SHRSP-(D2Mit5-D2Mgh12)/Gcrc,male,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,163,mmHg,3.8,6.5818,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65699,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0001059,WKY.SHRSP-(D2Mit5-D2Mgh12)/Gcrc,female,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,140.7,mmHg,8.0,13.8564,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65700,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0001059,WKY.SHRSP-(D2Mit5-D2Mgh12)/Gcrc,female,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,149.3,mmHg,7.0,12.1244,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65701,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0001062,WKY.SHRSP-(Fst-Pklr)/Gcrc,male,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,146.1,mmHg,2.2,3.8105,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65710,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0001062,WKY.SHRSP-(Fst-Pklr)/Gcrc,male,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,156,mmHg,2.5,4.3301,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65711,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0001062,WKY.SHRSP-(Fst-Pklr)/Gcrc,female,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,120.6,mmHg,8.5,14.7224,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65712,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0001062,WKY.SHRSP-(Fst-Pklr)/Gcrc,female,147 days to 126 days,3,,CMO:0000004,systolic blood pressure,,,continuous mean,130.6,mmHg,8.2,14.2028,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65713,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000760,SHRSP/Gcrc,male,147 days to 126 days,3,,CMO:0000005,diastolic blood pressure,,,continuous mean,152.9,mmHg,5.2,9.0067,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65654,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000760,SHRSP/Gcrc,male,147 days to 126 days,3,,CMO:0000005,diastolic blood pressure,,,continuous mean,167.2,mmHg,5.2,9.0067,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65655,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000760,SHRSP/Gcrc,female,147 days to 126 days,3,,CMO:0000005,diastolic blood pressure,,,continuous mean,121.7,mmHg,3.1,5.3694,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65656,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000760,SHRSP/Gcrc,female,147 days to 126 days,3,,CMO:0000005,diastolic blood pressure,,,continuous mean,134.6,mmHg,3.5,6.0622,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65657,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000761,WKY/Gcrc,male,147 days to 126 days,4,,CMO:0000005,diastolic blood pressure,,,continuous mean,96.8,mmHg,6.4,12.8,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65666,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000761,WKY/Gcrc,male,147 days to 126 days,4,,CMO:0000005,diastolic blood pressure,,,continuous mean,104.4,mmHg,6.9,13.8,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65667,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000761,WKY/Gcrc,female,147 days to 126 days,3,,CMO:0000005,diastolic blood pressure,,,continuous mean,92,mmHg,2.9,5.0229,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65668,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000761,WKY/Gcrc,female,147 days to 126 days,3,,CMO:0000005,diastolic blood pressure,,,continuous mean,98.8,mmHg,2.8,4.8497,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65669,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000763,SHRSP.WKY-(D2Rat13-D2Rat157)/Gcrc,male,147 days to 126 days,3,,CMO:0000005,diastolic blood pressure,,,continuous mean,131.2,mmHg,5.5,9.5263,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65678,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000763,SHRSP.WKY-(D2Rat13-D2Rat157)/Gcrc,male,147 days to 126 days,3,,CMO:0000005,diastolic blood pressure,,,continuous mean,139,mmHg,8.1,14.0296,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65679,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000763,SHRSP.WKY-(D2Rat13-D2Rat157)/Gcrc,female,147 days to 126 days,3,,CMO:0000005,diastolic blood pressure,,,continuous mean,108.5,mmHg,3.6,6.2354,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65680,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000763,SHRSP.WKY-(D2Rat13-D2Rat157)/Gcrc,female,147 days to 126 days,3,,CMO:0000005,diastolic blood pressure,,,continuous mean,115.4,mmHg,4.4,7.621,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65681,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000764,SHRSP.WKY-(D2Rat13-D2Mit5)/Gcrc,male,147 days to 126 days,3,,CMO:0000005,diastolic blood pressure,,,continuous mean,144.2,mmHg,12.1,20.9578,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65690,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000764,SHRSP.WKY-(D2Rat13-D2Mit5)/Gcrc,male,147 days to 126 days,3,,CMO:0000005,diastolic blood pressure,,,continuous mean,156.8,mmHg,11.8,20.4382,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65691,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000764,SHRSP.WKY-(D2Rat13-D2Mit5)/Gcrc,female,147 days to 126 days,3,,CMO:0000005,diastolic blood pressure,,,continuous mean,117.4,mmHg,3.9,6.755,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65692,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0000764,SHRSP.WKY-(D2Rat13-D2Mit5)/Gcrc,female,147 days to 126 days,3,,CMO:0000005,diastolic blood pressure,,,continuous mean,127.9,mmHg,4.0,6.9282,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65693,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0001059,WKY.SHRSP-(D2Mit5-D2Mgh12)/Gcrc,male,147 days to 126 days,3,,CMO:0000005,diastolic blood pressure,,,continuous mean,112,mmHg,5.6,9.6995,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65702,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0001059,WKY.SHRSP-(D2Mit5-D2Mgh12)/Gcrc,male,147 days to 126 days,3,,CMO:0000005,diastolic blood pressure,,,continuous mean,118.2,mmHg,5.6,9.6995,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65703,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0001059,WKY.SHRSP-(D2Mit5-D2Mgh12)/Gcrc,female,147 days to 126 days,3,,CMO:0000005,diastolic blood pressure,,,continuous mean,97.8,mmHg,6.8,11.7779,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65704,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0001059,WKY.SHRSP-(D2Mit5-D2Mgh12)/Gcrc,female,147 days to 126 days,3,,CMO:0000005,diastolic blood pressure,,,continuous mean,105.4,mmHg,6.3,10.9119,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65705,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0001062,WKY.SHRSP-(Fst-Pklr)/Gcrc,male,147 days to 126 days,3,,CMO:0000005,diastolic blood pressure,,,continuous mean,99.5,mmHg,1.2,2.0785,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65714,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0001062,WKY.SHRSP-(Fst-Pklr)/Gcrc,male,147 days to 126 days,3,,CMO:0000005,diastolic blood pressure,,,continuous mean,108.4,mmHg,1.4,2.4249,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65715,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0001062,WKY.SHRSP-(Fst-Pklr)/Gcrc,female,147 days to 126 days,3,,CMO:0000005,diastolic blood pressure,,,continuous mean,83.1,mmHg,6.6,11.4315,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Days (7 AM to 7 PM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to ambient light,65716,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to ambient light,,,,, 613,"Jeffs B, et al., Hypertension 2000 Jan;35(1 Pt 2):179-87.",arterial blood pressure trait,,RS:0001062,WKY.SHRSP-(Fst-Pklr)/Gcrc,female,147 days to 126 days,3,,CMO:0000005,diastolic blood pressure,,,continuous mean,91.9,mmHg,7.4,12.8172,MMO:0000070,intra-aortic abdominal radiotelemetry,,1814400,Nights (7 PM to 7 AM),,,,controlled sodium content drinking water (1 %) (for 21 days) and controlled exposure to darkness,65717,controlled sodium content drinking water (1 %) (for 21 days),controlled exposure to darkness,,,,, 1125,"Rubattu S, et al., Nat Genet 1996 Aug;13(4):429-34",cerebrovascular system integrity trait,,RS:0001444,SHRSP/Bbb,both,84 days,30,,CMO:0000932,percentage of study population developing cerebrovascular lesions during a period of time,,,,100,%,,,MMO:0000111,ex vivo light microscopy,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 42 days) and controlled sodium content drinking water (1 %) (for 42 days) and controlled potassium content diet (6.3 mg/g) (for 42 days),69117,controlled sodium content diet (3.7 mg/g) (for 42 days),controlled sodium content drinking water (1 %) (for 42 days),controlled potassium content diet (6.3 mg/g) (for 42 days),,,, 1125,"Rubattu S, et al., Nat Genet 1996 Aug;13(4):429-34",cerebrovascular system integrity trait,,RS:0003421,SHR/Bbb,both,182 days,30,,CMO:0000932,percentage of study population developing cerebrovascular lesions during a period of time,,,,20,%,,,MMO:0000111,ex vivo light microscopy,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 140 days) and controlled sodium content drinking water (1 %) (for 140 days) and controlled potassium content diet (6.3 mg/g) (for 140 days),69118,controlled sodium content diet (3.7 mg/g) (for 140 days),controlled sodium content drinking water (1 %) (for 140 days),controlled potassium content diet (6.3 mg/g) (for 140 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",cerebrovascular system integrity trait,,RS:0001444,SHRSP/Bbb,not specified,88 days to 70 days,31,,CMO:0000932,percentage of study population developing cerebrovascular lesions during a period of time,,,,100,%,,,MMO:0000111,ex vivo light microscopy,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (between 70 and 88 days) and controlled sodium content drinking water (1 %) (between 70 and 88 days) and controlled potassium content diet (6.3 mg/g) (between 70 and 88 days),69119,controlled sodium content diet (3.7 mg/g) (between 70 and 88 days),controlled sodium content drinking water (1 %) (between 70 and 88 days),controlled potassium content diet (6.3 mg/g) (between 70 and 88 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",cerebrovascular system integrity trait,,RS:0002192,SHRSR/Bbb,not specified,126 days,18,,CMO:0000932,percentage of study population developing cerebrovascular lesions during a period of time,,,,0,%,,,MMO:0000111,ex vivo light microscopy,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 84 days) and controlled sodium content drinking water (1 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days),69120,controlled sodium content diet (3.7 mg/g) (for 84 days),controlled sodium content drinking water (1 %) (for 84 days),controlled potassium content diet (6.3 mg/g) (for 84 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",cerebrovascular system integrity trait,,RS:0002535,SHRSP.SHRSR-(Klk1-Mt1-ps1)/Bbb,not specified,91 days to 70 days,20,,CMO:0000932,percentage of study population developing cerebrovascular lesions during a period of time,,,,61,%,,,MMO:0000111,ex vivo light microscopy,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (between 28 and 49 days) and controlled sodium content drinking water (1 %) (between 28 and 49 days) and controlled potassium content diet (6.3 mg/g) (between 28 and 49 days),69121,controlled sodium content diet (3.7 mg/g) (between 28 and 49 days),controlled sodium content drinking water (1 %) (between 28 and 49 days),controlled potassium content diet (6.3 mg/g) (between 28 and 49 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",cerebrovascular system integrity trait,,RS:0002537,SHRSP.SHRSR-(D1Rat134-Mt1-ps1)/Bbb,not specified,91 days to 70 days,34,,CMO:0000932,percentage of study population developing cerebrovascular lesions during a period of time,,,,63,%,,,MMO:0000111,ex vivo light microscopy,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (between 28 and 49 days) and controlled sodium content drinking water (1 %) (between 28 and 49 days) and controlled potassium content diet (6.3 mg/g) (between 28 and 49 days),69122,controlled sodium content diet (3.7 mg/g) (between 28 and 49 days),controlled sodium content drinking water (1 %) (between 28 and 49 days),controlled potassium content diet (6.3 mg/g) (between 28 and 49 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",cerebrovascular system integrity trait,,RS:0002195,SHRSR.SHRSP-(Klk1-Mt1-ps1)/Bbb,not specified,133 days to 81 days,33,,CMO:0000932,percentage of study population developing cerebrovascular lesions during a period of time,,,,20,%,,,MMO:0000111,ex vivo light microscopy,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (between 42 and 91 days) and controlled sodium content drinking water (1 %) (between 42 and 91 days) and controlled potassium content diet (6.3 mg/g) (between 42 and 91 days),69123,controlled sodium content diet (3.7 mg/g) (between 42 and 91 days),controlled sodium content drinking water (1 %) (between 42 and 91 days),controlled potassium content diet (6.3 mg/g) (between 42 and 91 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",cerebrovascular system integrity trait,,RS:0002193,SHRSR.SHRSP-(D1Rat134-Mt1-ps1)/Bbb,not specified,133 days to 81 days,31,,CMO:0000932,percentage of study population developing cerebrovascular lesions during a period of time,,,,20,%,,,MMO:0000111,ex vivo light microscopy,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (between 42 and 91 days) and controlled sodium content drinking water (1 %) (between 42 and 91 days) and controlled potassium content diet (6.3 mg/g) (between 42 and 91 days),69124,controlled sodium content diet (3.7 mg/g) (between 42 and 91 days),controlled sodium content drinking water (1 %) (between 42 and 91 days),controlled potassium content diet (6.3 mg/g) (between 42 and 91 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",cerebrovascular system integrity trait,,RS:0002535,SHRSP.SHRSR-(Klk1-Mt1-ps1)/Bbb,not specified,109 days to 70 days,33,,CMO:0000932,percentage of study population developing cerebrovascular lesions during a period of time,,,,100,%,,,MMO:0000111,ex vivo light microscopy,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (between 28 and 67 days) and controlled sodium content drinking water (1 %) (between 28 and 67 days) and controlled potassium content diet (6.3 mg/g) (between 28 and 67 days),84575,controlled sodium content diet (3.7 mg/g) (between 28 and 67 days),controlled sodium content drinking water (1 %) (between 28 and 67 days),controlled potassium content diet (6.3 mg/g) (between 28 and 67 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",cerebrovascular system integrity trait,,RS:0002537,SHRSP.SHRSR-(D1Rat134-Mt1-ps1)/Bbb,not specified,133 days to 70 days,35,,CMO:0000932,percentage of study population developing cerebrovascular lesions during a period of time,,,,100,%,,,MMO:0000111,ex vivo light microscopy,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (between 28 and 91 days) and controlled sodium content drinking water (1 %) (between 28 and 91 days) and controlled potassium content diet (6.3 mg/g) (between 28 and 91 days),84576,controlled sodium content diet (3.7 mg/g) (between 28 and 91 days),controlled sodium content drinking water (1 %) (between 28 and 91 days),controlled potassium content diet (6.3 mg/g) (between 28 and 91 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0001444,SHRSP/Bbb,not specified,56 days,31,,CMO:0000004,systolic blood pressure,,,,151,mmHg,1.4368,8.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 14 days) and controlled sodium content drinking water (1 %) (for 14 days) and controlled potassium content diet (6.3 mg/g) (for 14 days),69162,controlled sodium content diet (3.7 mg/g) (for 14 days),controlled sodium content drinking water (1 %) (for 14 days),controlled potassium content diet (6.3 mg/g) (for 14 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0001444,SHRSP/Bbb,not specified,70 days,26,,CMO:0000004,systolic blood pressure,,,,187,mmHg,2.5495,13.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 28 days) and controlled sodium content drinking water (1 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days),69163,controlled sodium content diet (3.7 mg/g) (for 28 days),controlled sodium content drinking water (1 %) (for 28 days),controlled potassium content diet (6.3 mg/g) (for 28 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0001444,SHRSP/Bbb,not specified,84 days,5,,CMO:0000004,systolic blood pressure,,,,201,mmHg,8.7207,19.5,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 42 days) and controlled sodium content drinking water (1 %) (for 42 days) and controlled potassium content diet (6.3 mg/g) (for 42 days),69164,controlled sodium content diet (3.7 mg/g) (for 42 days),controlled sodium content drinking water (1 %) (for 42 days),controlled potassium content diet (6.3 mg/g) (for 42 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002195,SHRSR.SHRSP-(Klk1-Mt1-ps1)/Bbb,not specified,56 days,33,,CMO:0000004,systolic blood pressure,,,,148,mmHg,3.1334,18.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 14 days) and controlled sodium content drinking water (1 %) (for 14 days) and controlled potassium content diet (6.3 mg/g) (for 14 days),69166,controlled sodium content diet (3.7 mg/g) (for 14 days),controlled sodium content drinking water (1 %) (for 14 days),controlled potassium content diet (6.3 mg/g) (for 14 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002195,SHRSR.SHRSP-(Klk1-Mt1-ps1)/Bbb,not specified,70 days,33,,CMO:0000004,systolic blood pressure,,,,174,mmHg,3.3075,19.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 28 days) and controlled sodium content drinking water (1 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days),69167,controlled sodium content diet (3.7 mg/g) (for 28 days),controlled sodium content drinking water (1 %) (for 28 days),controlled potassium content diet (6.3 mg/g) (for 28 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002195,SHRSR.SHRSP-(Klk1-Mt1-ps1)/Bbb,not specified,84 days,33,,CMO:0000004,systolic blood pressure,,,,192,mmHg,1.2185,7.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 42 days) and controlled sodium content drinking water (1 %) (for 42 days) and controlled potassium content diet (6.3 mg/g) (for 42 days),69168,controlled sodium content diet (3.7 mg/g) (for 42 days),controlled sodium content drinking water (1 %) (for 42 days),controlled potassium content diet (6.3 mg/g) (for 42 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002195,SHRSR.SHRSP-(Klk1-Mt1-ps1)/Bbb,not specified,98 days,32,,CMO:0000004,systolic blood pressure,,,,199,mmHg,1.7678,10.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 56 days) and controlled sodium content drinking water (1 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days),69169,controlled sodium content diet (3.7 mg/g) (for 56 days),controlled sodium content drinking water (1 %) (for 56 days),controlled potassium content diet (6.3 mg/g) (for 56 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002195,SHRSR.SHRSP-(Klk1-Mt1-ps1)/Bbb,not specified,112 days,29,,CMO:0000004,systolic blood pressure,,,,202,mmHg,1.6713,9.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 70 days) and controlled sodium content drinking water (1 %) (for 70 days) and controlled potassium content diet (6.3 mg/g) (for 70 days),69170,controlled sodium content diet (3.7 mg/g) (for 70 days),controlled sodium content drinking water (1 %) (for 70 days),controlled potassium content diet (6.3 mg/g) (for 70 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002195,SHRSR.SHRSP-(Klk1-Mt1-ps1)/Bbb,not specified,126 days,26,,CMO:0000004,systolic blood pressure,,,,197,mmHg,4.1184,21.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 84 days) and controlled sodium content drinking water (1 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days),69171,controlled sodium content diet (3.7 mg/g) (for 84 days),controlled sodium content drinking water (1 %) (for 84 days),controlled potassium content diet (6.3 mg/g) (for 84 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002194,SHRSR.SHRSP-(Klk1-D1Mit3)/Bbb,not specified,56 days,31,,CMO:0000004,systolic blood pressure,,,,146,mmHg,1.2572,7.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 14 days) and controlled sodium content drinking water (1 %) (for 14 days) and controlled potassium content diet (6.3 mg/g) (for 14 days),69173,controlled sodium content diet (3.7 mg/g) (for 14 days),controlled sodium content drinking water (1 %) (for 14 days),controlled potassium content diet (6.3 mg/g) (for 14 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002194,SHRSR.SHRSP-(Klk1-D1Mit3)/Bbb,not specified,70 days,31,,CMO:0000004,systolic blood pressure,,,,176,mmHg,1.8859,10.5,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 28 days) and controlled sodium content drinking water (1 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days),69174,controlled sodium content diet (3.7 mg/g) (for 28 days),controlled sodium content drinking water (1 %) (for 28 days),controlled potassium content diet (6.3 mg/g) (for 28 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002194,SHRSR.SHRSP-(Klk1-D1Mit3)/Bbb,not specified,84 days,31,,CMO:0000004,systolic blood pressure,,,,181,mmHg,1.6524,9.2,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 42 days) and controlled sodium content drinking water (1 %) (for 42 days) and controlled potassium content diet (6.3 mg/g) (for 42 days),69175,controlled sodium content diet (3.7 mg/g) (for 42 days),controlled sodium content drinking water (1 %) (for 42 days),controlled potassium content diet (6.3 mg/g) (for 42 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002194,SHRSR.SHRSP-(Klk1-D1Mit3)/Bbb,not specified,98 days,31,,CMO:0000004,systolic blood pressure,,,,197,mmHg,1.7961,10.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 56 days) and controlled sodium content drinking water (1 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days),69176,controlled sodium content diet (3.7 mg/g) (for 56 days),controlled sodium content drinking water (1 %) (for 56 days),controlled potassium content diet (6.3 mg/g) (for 56 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002194,SHRSR.SHRSP-(Klk1-D1Mit3)/Bbb,not specified,112 days,31,,CMO:0000004,systolic blood pressure,,,,206,mmHg,1.4368,8.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 70 days) and controlled sodium content drinking water (1 %) (for 70 days) and controlled potassium content diet (6.3 mg/g) (for 70 days),69177,controlled sodium content diet (3.7 mg/g) (for 70 days),controlled sodium content drinking water (1 %) (for 70 days),controlled potassium content diet (6.3 mg/g) (for 70 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002194,SHRSR.SHRSP-(Klk1-D1Mit3)/Bbb,not specified,126 days,31,,CMO:0000004,systolic blood pressure,,,,208,mmHg,1.4368,8.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 84 days) and controlled sodium content drinking water (1 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days),69178,controlled sodium content diet (3.7 mg/g) (for 84 days),controlled sodium content drinking water (1 %) (for 84 days),controlled potassium content diet (6.3 mg/g) (for 84 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002193,SHRSR.SHRSP-(D1Rat134-Mt1-ps1)/Bbb,not specified,56 days,31,,CMO:0000004,systolic blood pressure,,,,144,mmHg,1.9757,11.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 14 days) and controlled sodium content drinking water (1 %) (for 14 days) and controlled potassium content diet (6.3 mg/g) (for 14 days),69180,controlled sodium content diet (3.7 mg/g) (for 14 days),controlled sodium content drinking water (1 %) (for 14 days),controlled potassium content diet (6.3 mg/g) (for 14 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002193,SHRSR.SHRSP-(D1Rat134-Mt1-ps1)/Bbb,not specified,70 days,31,,CMO:0000004,systolic blood pressure,,,,166,mmHg,1.9577,10.9,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 28 days) and controlled sodium content drinking water (1 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days),69181,controlled sodium content diet (3.7 mg/g) (for 28 days),controlled sodium content drinking water (1 %) (for 28 days),controlled potassium content diet (6.3 mg/g) (for 28 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002193,SHRSR.SHRSP-(D1Rat134-Mt1-ps1)/Bbb,not specified,84 days,31,,CMO:0000004,systolic blood pressure,,,,191,mmHg,0.7184,4.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 42 days) and controlled sodium content drinking water (1 %) (for 42 days) and controlled potassium content diet (6.3 mg/g) (for 42 days),69182,controlled sodium content diet (3.7 mg/g) (for 42 days),controlled sodium content drinking water (1 %) (for 42 days),controlled potassium content diet (6.3 mg/g) (for 42 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002193,SHRSR.SHRSP-(D1Rat134-Mt1-ps1)/Bbb,not specified,98 days,30,,CMO:0000004,systolic blood pressure,,,,195,mmHg,1.4606,8.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 56 days) and controlled sodium content drinking water (1 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days),69183,controlled sodium content diet (3.7 mg/g) (for 56 days),controlled sodium content drinking water (1 %) (for 56 days),controlled potassium content diet (6.3 mg/g) (for 56 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002193,SHRSR.SHRSP-(D1Rat134-Mt1-ps1)/Bbb,not specified,112 days,28,,CMO:0000004,systolic blood pressure,,,,199,mmHg,1.8898,10.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 70 days) and controlled sodium content drinking water (1 %) (for 70 days) and controlled potassium content diet (6.3 mg/g) (for 70 days),69184,controlled sodium content diet (3.7 mg/g) (for 70 days),controlled sodium content drinking water (1 %) (for 70 days),controlled potassium content diet (6.3 mg/g) (for 70 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002193,SHRSR.SHRSP-(D1Rat134-Mt1-ps1)/Bbb,not specified,126 days,25,,CMO:0000004,systolic blood pressure,,,,201,mmHg,1.4,7.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 84 days) and controlled sodium content drinking water (1 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days),69185,controlled sodium content diet (3.7 mg/g) (for 84 days),controlled sodium content drinking water (1 %) (for 84 days),controlled potassium content diet (6.3 mg/g) (for 84 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002535,SHRSP.SHRSR-(Klk1-Mt1-ps1)/Bbb,not specified,56 days,33,,CMO:0000004,systolic blood pressure,,,,164,mmHg,2.6112,15.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 14 days) and controlled sodium content drinking water (1 %) (for 14 days) and controlled potassium content diet (6.3 mg/g) (for 14 days),69187,controlled sodium content diet (3.7 mg/g) (for 14 days),controlled sodium content drinking water (1 %) (for 14 days),controlled potassium content diet (6.3 mg/g) (for 14 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002535,SHRSP.SHRSR-(Klk1-Mt1-ps1)/Bbb,not specified,70 days,33,,CMO:0000004,systolic blood pressure,,,,186,mmHg,1.2011,6.9,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 28 days) and controlled sodium content drinking water (1 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days),69188,controlled sodium content diet (3.7 mg/g) (for 28 days),controlled sodium content drinking water (1 %) (for 28 days),controlled potassium content diet (6.3 mg/g) (for 28 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002535,SHRSP.SHRSR-(Klk1-Mt1-ps1)/Bbb,not specified,84 days,20,,CMO:0000004,systolic blood pressure,,,,192,mmHg,1.5652,7.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 42 days) and controlled sodium content drinking water (1 %) (for 42 days) and controlled potassium content diet (6.3 mg/g) (for 42 days),69189,controlled sodium content diet (3.7 mg/g) (for 42 days),controlled sodium content drinking water (1 %) (for 42 days),controlled potassium content diet (6.3 mg/g) (for 42 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002535,SHRSP.SHRSR-(Klk1-Mt1-ps1)/Bbb,not specified,98 days,3,,CMO:0000004,systolic blood pressure,,,,195,mmHg,2.8868,5.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 56 days) and controlled sodium content drinking water (1 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days),69190,controlled sodium content diet (3.7 mg/g) (for 56 days),controlled sodium content drinking water (1 %) (for 56 days),controlled potassium content diet (6.3 mg/g) (for 56 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002536,SHRSP.SHRSR-(Klk1-D1Mit3)/Bbb,not specified,56 days,31,,CMO:0000004,systolic blood pressure,,,,153,mmHg,2.1553,12.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 14 days) and controlled sodium content drinking water (1 %) (for 14 days) and controlled potassium content diet (6.3 mg/g) (for 14 days),69192,controlled sodium content diet (3.7 mg/g) (for 14 days),controlled sodium content drinking water (1 %) (for 14 days),controlled potassium content diet (6.3 mg/g) (for 14 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002536,SHRSP.SHRSR-(Klk1-D1Mit3)/Bbb,not specified,70 days,31,,CMO:0000004,systolic blood pressure,,,,190,mmHg,0.898,5.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 28 days) and controlled sodium content drinking water (1 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days),69193,controlled sodium content diet (3.7 mg/g) (for 28 days),controlled sodium content drinking water (1 %) (for 28 days),controlled potassium content diet (6.3 mg/g) (for 28 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002536,SHRSP.SHRSR-(Klk1-D1Mit3)/Bbb,not specified,84 days,22,,CMO:0000004,systolic blood pressure,,,,200,mmHg,0.8528,4.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 42 days) and controlled sodium content drinking water (1 %) (for 42 days) and controlled potassium content diet (6.3 mg/g) (for 42 days),69194,controlled sodium content diet (3.7 mg/g) (for 42 days),controlled sodium content drinking water (1 %) (for 42 days),controlled potassium content diet (6.3 mg/g) (for 42 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002537,SHRSP.SHRSR-(D1Rat134-Mt1-ps1)/Bbb,not specified,56 days,35,,CMO:0000004,systolic blood pressure,,,,153,mmHg,2.0284,12.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 14 days) and controlled sodium content drinking water (1 %) (for 14 days) and controlled potassium content diet (6.3 mg/g) (for 14 days),69196,controlled sodium content diet (3.7 mg/g) (for 14 days),controlled sodium content drinking water (1 %) (for 14 days),controlled potassium content diet (6.3 mg/g) (for 14 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002537,SHRSP.SHRSR-(D1Rat134-Mt1-ps1)/Bbb,not specified,70 days,35,,CMO:0000004,systolic blood pressure,,,,188,mmHg,2.1129,12.5,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 28 days) and controlled sodium content drinking water (1 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days),69197,controlled sodium content diet (3.7 mg/g) (for 28 days),controlled sodium content drinking water (1 %) (for 28 days),controlled potassium content diet (6.3 mg/g) (for 28 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002537,SHRSP.SHRSR-(D1Rat134-Mt1-ps1)/Bbb,not specified,84 days,34,,CMO:0000004,systolic blood pressure,,,,192,mmHg,0.7889,4.6,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 42 days) and controlled sodium content drinking water (1 %) (for 42 days) and controlled potassium content diet (6.3 mg/g) (for 42 days),69198,controlled sodium content diet (3.7 mg/g) (for 42 days),controlled sodium content drinking water (1 %) (for 42 days),controlled potassium content diet (6.3 mg/g) (for 42 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002537,SHRSP.SHRSR-(D1Rat134-Mt1-ps1)/Bbb,not specified,98 days,14,,CMO:0000004,systolic blood pressure,,,,192,mmHg,1.6036,6.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 56 days) and controlled sodium content drinking water (1 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days),69199,controlled sodium content diet (3.7 mg/g) (for 56 days),controlled sodium content drinking water (1 %) (for 56 days),controlled potassium content diet (6.3 mg/g) (for 56 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002537,SHRSP.SHRSR-(D1Rat134-Mt1-ps1)/Bbb,not specified,112 days,5,,CMO:0000004,systolic blood pressure,,,,198,mmHg,1.3416,3.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 70 days) and controlled sodium content drinking water (1 %) (for 70 days) and controlled potassium content diet (6.3 mg/g) (for 70 days),69200,controlled sodium content diet (3.7 mg/g) (for 70 days),controlled sodium content drinking water (1 %) (for 70 days),controlled potassium content diet (6.3 mg/g) (for 70 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002537,SHRSP.SHRSR-(D1Rat134-Mt1-ps1)/Bbb,not specified,126 days,1,,CMO:0000004,systolic blood pressure,,,,193,mmHg,,,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 84 days) and controlled sodium content drinking water (1 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days),69201,controlled sodium content diet (3.7 mg/g) (for 84 days),controlled sodium content drinking water (1 %) (for 84 days),controlled potassium content diet (6.3 mg/g) (for 84 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002192,SHRSR/Bbb,not specified,56 days,18,,CMO:0000004,systolic blood pressure,,,,139,mmHg,1.6499,7.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 14 days) and controlled sodium content drinking water (1 %) (for 14 days) and controlled potassium content diet (6.3 mg/g) (for 14 days),69126,controlled sodium content diet (3.7 mg/g) (for 14 days),controlled sodium content drinking water (1 %) (for 14 days),controlled potassium content diet (6.3 mg/g) (for 14 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002192,SHRSR/Bbb,not specified,70 days,18,,CMO:0000004,systolic blood pressure,,,,185,mmHg,1.7206,7.3,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 28 days) and controlled sodium content drinking water (1 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days),69127,controlled sodium content diet (3.7 mg/g) (for 28 days),controlled sodium content drinking water (1 %) (for 28 days),controlled potassium content diet (6.3 mg/g) (for 28 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002192,SHRSR/Bbb,not specified,84 days,18,,CMO:0000004,systolic blood pressure,,,,191,mmHg,3.017,12.8,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 42 days) and controlled sodium content drinking water (1 %) (for 42 days) and controlled potassium content diet (6.3 mg/g) (for 42 days),69128,controlled sodium content diet (3.7 mg/g) (for 42 days),controlled sodium content drinking water (1 %) (for 42 days),controlled potassium content diet (6.3 mg/g) (for 42 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002192,SHRSR/Bbb,not specified,98 days,18,,CMO:0000004,systolic blood pressure,,,,191,mmHg,1.6499,7.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 56 days) and controlled sodium content drinking water (1 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days),69129,controlled sodium content diet (3.7 mg/g) (for 56 days),controlled sodium content drinking water (1 %) (for 56 days),controlled potassium content diet (6.3 mg/g) (for 56 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002192,SHRSR/Bbb,not specified,112 days,18,,CMO:0000004,systolic blood pressure,,,,199,mmHg,0.2357,1.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 70 days) and controlled sodium content drinking water (1 %) (for 70 days) and controlled potassium content diet (6.3 mg/g) (for 70 days),69130,controlled sodium content diet (3.7 mg/g) (for 70 days),controlled sodium content drinking water (1 %) (for 70 days),controlled potassium content diet (6.3 mg/g) (for 70 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",arterial blood pressure trait,,RS:0002192,SHRSR/Bbb,not specified,126 days,18,,CMO:0000004,systolic blood pressure,,,,188,mmHg,2.8284,12.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 84 days) and controlled sodium content drinking water (1 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days),69131,controlled sodium content diet (3.7 mg/g) (for 84 days),controlled sodium content drinking water (1 %) (for 84 days),controlled potassium content diet (6.3 mg/g) (for 84 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",total urine protein amount,,RS:0002194,SHRSR.SHRSP-(Klk1-D1Mit3)/Bbb,not specified,56 days,31,,CMO:0000756,urine total protein excretion rate,,,,22,mg/d,1.9038,10.6,MMO:0000426,Bradford protein assay,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 14 days) and controlled sodium content drinking water (1 %) (for 14 days) and controlled potassium content diet (6.3 mg/g) (for 14 days),70243,controlled sodium content diet (3.7 mg/g) (for 14 days),controlled sodium content drinking water (1 %) (for 14 days),controlled potassium content diet (6.3 mg/g) (for 14 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",total urine protein amount,,RS:0002194,SHRSR.SHRSP-(Klk1-D1Mit3)/Bbb,not specified,70 days,31,,CMO:0000756,urine total protein excretion rate,,,,74,mg/d,2.6941,15.0,MMO:0000426,Bradford protein assay,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 28 days) and controlled sodium content drinking water (1 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days),70244,controlled sodium content diet (3.7 mg/g) (for 28 days),controlled sodium content drinking water (1 %) (for 28 days),controlled potassium content diet (6.3 mg/g) (for 28 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",total urine protein amount,,RS:0002194,SHRSR.SHRSP-(Klk1-D1Mit3)/Bbb,not specified,84 days,31,,CMO:0000756,urine total protein excretion rate,,,,58,mg/d,5.0289,28.0,MMO:0000426,Bradford protein assay,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 42 days) and controlled sodium content drinking water (1 %) (for 42 days) and controlled potassium content diet (6.3 mg/g) (for 42 days),70245,controlled sodium content diet (3.7 mg/g) (for 42 days),controlled sodium content drinking water (1 %) (for 42 days),controlled potassium content diet (6.3 mg/g) (for 42 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",total urine protein amount,,RS:0002194,SHRSR.SHRSP-(Klk1-D1Mit3)/Bbb,not specified,98 days,31,,CMO:0000756,urine total protein excretion rate,,,,81,mg/d,4.1309,23.0,MMO:0000426,Bradford protein assay,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 56 days) and controlled sodium content drinking water (1 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days),70246,controlled sodium content diet (3.7 mg/g) (for 56 days),controlled sodium content drinking water (1 %) (for 56 days),controlled potassium content diet (6.3 mg/g) (for 56 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",total urine protein amount,,RS:0002194,SHRSR.SHRSP-(Klk1-D1Mit3)/Bbb,not specified,112 days,31,,CMO:0000756,urine total protein excretion rate,,,,89,mg/d,12.752,71.0,MMO:0000426,Bradford protein assay,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 70 days) and controlled sodium content drinking water (1 %) (for 70 days) and controlled potassium content diet (6.3 mg/g) (for 70 days),70247,controlled sodium content diet (3.7 mg/g) (for 70 days),controlled sodium content drinking water (1 %) (for 70 days),controlled potassium content diet (6.3 mg/g) (for 70 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",total urine protein amount,,RS:0002194,SHRSR.SHRSP-(Klk1-D1Mit3)/Bbb,not specified,126 days,31,,CMO:0000756,urine total protein excretion rate,,,,58,mg/d,1.3291,7.4,MMO:0000426,Bradford protein assay,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 84 days) and controlled sodium content drinking water (1 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days),70248,controlled sodium content diet (3.7 mg/g) (for 84 days),controlled sodium content drinking water (1 %) (for 84 days),controlled potassium content diet (6.3 mg/g) (for 84 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",total urine protein amount,,RS:0002193,SHRSR.SHRSP-(D1Rat134-Mt1-ps1)/Bbb,not specified,56 days,31,,CMO:0000756,urine total protein excretion rate,,,,11,mg/d,0.2694,1.5,MMO:0000426,Bradford protein assay,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 14 days) and controlled sodium content drinking water (1 %) (for 14 days) and controlled potassium content diet (6.3 mg/g) (for 14 days),70250,controlled sodium content diet (3.7 mg/g) (for 14 days),controlled sodium content drinking water (1 %) (for 14 days),controlled potassium content diet (6.3 mg/g) (for 14 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",total urine protein amount,,RS:0002193,SHRSR.SHRSP-(D1Rat134-Mt1-ps1)/Bbb,not specified,70 days,31,,CMO:0000756,urine total protein excretion rate,,,,60,mg/d,2.5145,14.0,MMO:0000426,Bradford protein assay,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 28 days) and controlled sodium content drinking water (1 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days),70251,controlled sodium content diet (3.7 mg/g) (for 28 days),controlled sodium content drinking water (1 %) (for 28 days),controlled potassium content diet (6.3 mg/g) (for 28 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",total urine protein amount,,RS:0002193,SHRSR.SHRSP-(D1Rat134-Mt1-ps1)/Bbb,not specified,84 days,31,,CMO:0000756,urine total protein excretion rate,,,,51,mg/d,3.9513,22.0,MMO:0000426,Bradford protein assay,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 42 days) and controlled sodium content drinking water (1 %) (for 42 days) and controlled potassium content diet (6.3 mg/g) (for 42 days),70252,controlled sodium content diet (3.7 mg/g) (for 42 days),controlled sodium content drinking water (1 %) (for 42 days),controlled potassium content diet (6.3 mg/g) (for 42 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",total urine protein amount,,RS:0002193,SHRSR.SHRSP-(D1Rat134-Mt1-ps1)/Bbb,not specified,98 days,30,,CMO:0000756,urine total protein excretion rate,,,,54,mg/d,4.9295,27.0,MMO:0000426,Bradford protein assay,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 56 days) and controlled sodium content drinking water (1 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days),70253,controlled sodium content diet (3.7 mg/g) (for 56 days),controlled sodium content drinking water (1 %) (for 56 days),controlled potassium content diet (6.3 mg/g) (for 56 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",total urine protein amount,,RS:0002193,SHRSR.SHRSP-(D1Rat134-Mt1-ps1)/Bbb,not specified,112 days,28,,CMO:0000756,urine total protein excretion rate,,,,169,mg/d,16.2525,86.0,MMO:0000426,Bradford protein assay,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 70 days) and controlled sodium content drinking water (1 %) (for 70 days) and controlled potassium content diet (6.3 mg/g) (for 70 days),70254,controlled sodium content diet (3.7 mg/g) (for 70 days),controlled sodium content drinking water (1 %) (for 70 days),controlled potassium content diet (6.3 mg/g) (for 70 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",total urine protein amount,,RS:0002193,SHRSR.SHRSP-(D1Rat134-Mt1-ps1)/Bbb,not specified,126 days,25,,CMO:0000756,urine total protein excretion rate,,,,111,mg/d,17.2,86.0,MMO:0000426,Bradford protein assay,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 84 days) and controlled sodium content drinking water (1 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days),70255,controlled sodium content diet (3.7 mg/g) (for 84 days),controlled sodium content drinking water (1 %) (for 84 days),controlled potassium content diet (6.3 mg/g) (for 84 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",total urine protein amount,,RS:0002535,SHRSP.SHRSR-(Klk1-Mt1-ps1)/Bbb,not specified,56 days,33,,CMO:0000756,urine total protein excretion rate,,,,38,mg/d,1.9149,11.0,MMO:0000426,Bradford protein assay,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 14 days) and controlled sodium content drinking water (1 %) (for 14 days) and controlled potassium content diet (6.3 mg/g) (for 14 days),70257,controlled sodium content diet (3.7 mg/g) (for 14 days),controlled sodium content drinking water (1 %) (for 14 days),controlled potassium content diet (6.3 mg/g) (for 14 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",total urine protein amount,,RS:0002535,SHRSP.SHRSR-(Klk1-Mt1-ps1)/Bbb,not specified,70 days,33,,CMO:0000756,urine total protein excretion rate,,,,30,mg/d,0.9226,5.3,MMO:0000426,Bradford protein assay,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 28 days) and controlled sodium content drinking water (1 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days),70258,controlled sodium content diet (3.7 mg/g) (for 28 days),controlled sodium content drinking water (1 %) (for 28 days),controlled potassium content diet (6.3 mg/g) (for 28 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",total urine protein amount,,RS:0002535,SHRSP.SHRSR-(Klk1-Mt1-ps1)/Bbb,not specified,84 days,20,,CMO:0000756,urine total protein excretion rate,,,,232,mg/d,20.3482,91.0,MMO:0000426,Bradford protein assay,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 42 days) and controlled sodium content drinking water (1 %) (for 42 days) and controlled potassium content diet (6.3 mg/g) (for 42 days),70259,controlled sodium content diet (3.7 mg/g) (for 42 days),controlled sodium content drinking water (1 %) (for 42 days),controlled potassium content diet (6.3 mg/g) (for 42 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",total urine protein amount,,RS:0002535,SHRSP.SHRSR-(Klk1-Mt1-ps1)/Bbb,not specified,98 days,3,,CMO:0000756,urine total protein excretion rate,,,,351,mg/d,28.8675,50.0,MMO:0000426,Bradford protein assay,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 56 days) and controlled sodium content drinking water (1 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days),70260,controlled sodium content diet (3.7 mg/g) (for 56 days),controlled sodium content drinking water (1 %) (for 56 days),controlled potassium content diet (6.3 mg/g) (for 56 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",total urine protein amount,,RS:0002192,SHRSR/Bbb,not specified,56 days,18,,CMO:0000756,urine total protein excretion rate,,,,31,mg/d,3.2998,14.0,MMO:0000426,Bradford protein assay,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 14 days) and controlled sodium content drinking water (1 %) (for 14 days) and controlled potassium content diet (6.3 mg/g) (for 14 days),69209,controlled sodium content diet (3.7 mg/g) (for 14 days),controlled sodium content drinking water (1 %) (for 14 days),controlled potassium content diet (6.3 mg/g) (for 14 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",total urine protein amount,,RS:0002192,SHRSR/Bbb,not specified,70 days,18,,CMO:0000756,urine total protein excretion rate,,,,60,mg/d,4.2426,18.0,MMO:0000426,Bradford protein assay,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 28 days) and controlled sodium content drinking water (1 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days),69210,controlled sodium content diet (3.7 mg/g) (for 28 days),controlled sodium content drinking water (1 %) (for 28 days),controlled potassium content diet (6.3 mg/g) (for 28 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",total urine protein amount,,RS:0002192,SHRSR/Bbb,not specified,84 days,18,,CMO:0000756,urine total protein excretion rate,,,,56,mg/d,0.9428,4.0,MMO:0000426,Bradford protein assay,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 42 days) and controlled sodium content drinking water (1 %) (for 42 days) and controlled potassium content diet (6.3 mg/g) (for 42 days),69211,controlled sodium content diet (3.7 mg/g) (for 42 days),controlled sodium content drinking water (1 %) (for 42 days),controlled potassium content diet (6.3 mg/g) (for 42 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",total urine protein amount,,RS:0002192,SHRSR/Bbb,not specified,98 days,18,,CMO:0000756,urine total protein excretion rate,,,,83,mg/d,1.0371,4.4,MMO:0000426,Bradford protein assay,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 56 days) and controlled sodium content drinking water (1 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days),69212,controlled sodium content diet (3.7 mg/g) (for 56 days),controlled sodium content drinking water (1 %) (for 56 days),controlled potassium content diet (6.3 mg/g) (for 56 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",total urine protein amount,,RS:0002192,SHRSR/Bbb,not specified,112 days,18,,CMO:0000756,urine total protein excretion rate,,,,80,mg/d,1.0607,4.5,MMO:0000426,Bradford protein assay,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 70 days) and controlled sodium content drinking water (1 %) (for 70 days) and controlled potassium content diet (6.3 mg/g) (for 70 days),69213,controlled sodium content diet (3.7 mg/g) (for 70 days),controlled sodium content drinking water (1 %) (for 70 days),controlled potassium content diet (6.3 mg/g) (for 70 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",total urine protein amount,,RS:0002192,SHRSR/Bbb,not specified,126 days,18,,CMO:0000756,urine total protein excretion rate,,,,89,mg/d,2.1213,9.0,MMO:0000426,Bradford protein assay,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 84 days) and controlled sodium content drinking water (1 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days),69214,controlled sodium content diet (3.7 mg/g) (for 84 days),controlled sodium content drinking water (1 %) (for 84 days),controlled potassium content diet (6.3 mg/g) (for 84 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",total urine protein amount,,RS:0001444,SHRSP/Bbb,not specified,56 days,31,,CMO:0000756,urine total protein excretion rate,,,,35,mg/d,0.6107,3.4,MMO:0000426,Bradford protein assay,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 14 days) and controlled sodium content drinking water (1 %) (for 14 days) and controlled potassium content diet (6.3 mg/g) (for 14 days),69216,controlled sodium content diet (3.7 mg/g) (for 14 days),controlled sodium content drinking water (1 %) (for 14 days),controlled potassium content diet (6.3 mg/g) (for 14 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",total urine protein amount,,RS:0001444,SHRSP/Bbb,not specified,70 days,26,,CMO:0000756,urine total protein excretion rate,,,,215,mg/d,18.4349,94.0,MMO:0000426,Bradford protein assay,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 28 days) and controlled sodium content drinking water (1 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days),69217,controlled sodium content diet (3.7 mg/g) (for 28 days),controlled sodium content drinking water (1 %) (for 28 days),controlled potassium content diet (6.3 mg/g) (for 28 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",total urine protein amount,,RS:0001444,SHRSP/Bbb,not specified,84 days,5,,CMO:0000756,urine total protein excretion rate,,,,194,mg/d,42.4853,95.0,MMO:0000426,Bradford protein assay,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 42 days) and controlled sodium content drinking water (1 %) (for 42 days) and controlled potassium content diet (6.3 mg/g) (for 42 days),69218,controlled sodium content diet (3.7 mg/g) (for 42 days),controlled sodium content drinking water (1 %) (for 42 days),controlled potassium content diet (6.3 mg/g) (for 42 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",total urine protein amount,,RS:0002195,SHRSR.SHRSP-(Klk1-Mt1-ps1)/Bbb,not specified,56 days,33,,CMO:0000756,urine total protein excretion rate,,,,37,mg/d,2.4371,14.0,MMO:0000426,Bradford protein assay,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 14 days) and controlled sodium content drinking water (1 %) (for 14 days) and controlled potassium content diet (6.3 mg/g) (for 14 days),69220,controlled sodium content diet (3.7 mg/g) (for 14 days),controlled sodium content drinking water (1 %) (for 14 days),controlled potassium content diet (6.3 mg/g) (for 14 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",total urine protein amount,,RS:0002195,SHRSR.SHRSP-(Klk1-Mt1-ps1)/Bbb,not specified,70 days,33,,CMO:0000756,urine total protein excretion rate,,,,46,mg/d,2.6112,15.0,MMO:0000426,Bradford protein assay,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 28 days) and controlled sodium content drinking water (1 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days),69221,controlled sodium content diet (3.7 mg/g) (for 28 days),controlled sodium content drinking water (1 %) (for 28 days),controlled potassium content diet (6.3 mg/g) (for 28 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",total urine protein amount,,RS:0002195,SHRSR.SHRSP-(Klk1-Mt1-ps1)/Bbb,not specified,84 days,33,,CMO:0000756,urine total protein excretion rate,,,,75,mg/d,3.3075,19.0,MMO:0000426,Bradford protein assay,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 42 days) and controlled sodium content drinking water (1 %) (for 42 days) and controlled potassium content diet (6.3 mg/g) (for 42 days),69222,controlled sodium content diet (3.7 mg/g) (for 42 days),controlled sodium content drinking water (1 %) (for 42 days),controlled potassium content diet (6.3 mg/g) (for 42 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",total urine protein amount,,RS:0002195,SHRSR.SHRSP-(Klk1-Mt1-ps1)/Bbb,not specified,98 days,32,,CMO:0000756,urine total protein excretion rate,,,,270,mg/d,6.0104,34.0,MMO:0000426,Bradford protein assay,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 56 days) and controlled sodium content drinking water (1 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days),69223,controlled sodium content diet (3.7 mg/g) (for 56 days),controlled sodium content drinking water (1 %) (for 56 days),controlled potassium content diet (6.3 mg/g) (for 56 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",total urine protein amount,,RS:0002195,SHRSR.SHRSP-(Klk1-Mt1-ps1)/Bbb,not specified,112 days,29,,CMO:0000756,urine total protein excretion rate,,,,241,mg/d,4.0853,22.0,MMO:0000426,Bradford protein assay,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 70 days) and controlled sodium content drinking water (1 %) (for 70 days) and controlled potassium content diet (6.3 mg/g) (for 70 days),69224,controlled sodium content diet (3.7 mg/g) (for 70 days),controlled sodium content drinking water (1 %) (for 70 days),controlled potassium content diet (6.3 mg/g) (for 70 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",total urine protein amount,,RS:0002195,SHRSR.SHRSP-(Klk1-Mt1-ps1)/Bbb,not specified,126 days,26,,CMO:0000756,urine total protein excretion rate,,,,294,mg/d,2.9417,15.0,MMO:0000426,Bradford protein assay,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 84 days) and controlled sodium content drinking water (1 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days),69225,controlled sodium content diet (3.7 mg/g) (for 84 days),controlled sodium content drinking water (1 %) (for 84 days),controlled potassium content diet (6.3 mg/g) (for 84 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",total urine protein amount,,RS:0002536,SHRSP.SHRSR-(Klk1-D1Mit3)/Bbb,not specified,56 days,31,,CMO:0000756,urine total protein excretion rate,,,,39,mg/d,4.3105,24.0,MMO:0000426,Bradford protein assay,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 14 days) and controlled sodium content drinking water (1 %) (for 14 days) and controlled potassium content diet (6.3 mg/g) (for 14 days),84578,controlled sodium content diet (3.7 mg/g) (for 14 days),controlled sodium content drinking water (1 %) (for 14 days),controlled potassium content diet (6.3 mg/g) (for 14 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",total urine protein amount,,RS:0002536,SHRSP.SHRSR-(Klk1-D1Mit3)/Bbb,not specified,70 days,31,,CMO:0000756,urine total protein excretion rate,,,,75,mg/d,6.4658,36.0,MMO:0000426,Bradford protein assay,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 28 days) and controlled sodium content drinking water (1 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days),84579,controlled sodium content diet (3.7 mg/g) (for 28 days),controlled sodium content drinking water (1 %) (for 28 days),controlled potassium content diet (6.3 mg/g) (for 28 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",total urine protein amount,,RS:0002536,SHRSP.SHRSR-(Klk1-D1Mit3)/Bbb,not specified,84 days,31,,CMO:0000756,urine total protein excretion rate,,,,257,mg/d,15.9849,89.0,MMO:0000426,Bradford protein assay,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 42 days) and controlled sodium content drinking water (1 %) (for 42 days) and controlled potassium content diet (6.3 mg/g) (for 42 days),84580,controlled sodium content diet (3.7 mg/g) (for 42 days),controlled sodium content drinking water (1 %) (for 42 days),controlled potassium content diet (6.3 mg/g) (for 42 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",total urine protein amount,,RS:0002537,SHRSP.SHRSR-(D1Rat134-Mt1-ps1)/Bbb,not specified,56 days,35,,CMO:0000756,urine total protein excretion rate,,,,24,mg/d,1.8593,11.0,MMO:0000426,Bradford protein assay,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 14 days) and controlled sodium content drinking water (1 %) (for 14 days) and controlled potassium content diet (6.3 mg/g) (for 14 days),84582,controlled sodium content diet (3.7 mg/g) (for 14 days),controlled sodium content drinking water (1 %) (for 14 days),controlled potassium content diet (6.3 mg/g) (for 14 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",total urine protein amount,,RS:0002537,SHRSP.SHRSR-(D1Rat134-Mt1-ps1)/Bbb,not specified,70 days,35,,CMO:0000756,urine total protein excretion rate,,,,53,mg/d,1.2677,7.5,MMO:0000426,Bradford protein assay,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 28 days) and controlled sodium content drinking water (1 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days),84583,controlled sodium content diet (3.7 mg/g) (for 28 days),controlled sodium content drinking water (1 %) (for 28 days),controlled potassium content diet (6.3 mg/g) (for 28 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",total urine protein amount,,RS:0002537,SHRSP.SHRSR-(D1Rat134-Mt1-ps1)/Bbb,not specified,84 days,34,,CMO:0000756,urine total protein excretion rate,,,,275,mg/d,14.4059,84.0,MMO:0000426,Bradford protein assay,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 42 days) and controlled sodium content drinking water (1 %) (for 42 days) and controlled potassium content diet (6.3 mg/g) (for 42 days),84584,controlled sodium content diet (3.7 mg/g) (for 42 days),controlled sodium content drinking water (1 %) (for 42 days),controlled potassium content diet (6.3 mg/g) (for 42 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",total urine protein amount,,RS:0002537,SHRSP.SHRSR-(D1Rat134-Mt1-ps1)/Bbb,not specified,98 days,14,,CMO:0000756,urine total protein excretion rate,,,,343,mg/d,16.0357,60.0,MMO:0000426,Bradford protein assay,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 56 days) and controlled sodium content drinking water (1 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days),84585,controlled sodium content diet (3.7 mg/g) (for 56 days),controlled sodium content drinking water (1 %) (for 56 days),controlled potassium content diet (6.3 mg/g) (for 56 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",total urine protein amount,,RS:0002537,SHRSP.SHRSR-(D1Rat134-Mt1-ps1)/Bbb,not specified,112 days,5,,CMO:0000756,urine total protein excretion rate,,,,333,mg/d,34.4354,77.0,MMO:0000426,Bradford protein assay,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 70 days) and controlled sodium content drinking water (1 %) (for 70 days) and controlled potassium content diet (6.3 mg/g) (for 70 days),84586,controlled sodium content diet (3.7 mg/g) (for 70 days),controlled sodium content drinking water (1 %) (for 70 days),controlled potassium content diet (6.3 mg/g) (for 70 days),,,, 1126,"Rubattu S, et al., Physiol Genomics. 2006 Oct 11;27(2):108-13. Epub 2006 Jul 11.",total urine protein amount,,RS:0002537,SHRSP.SHRSR-(D1Rat134-Mt1-ps1)/Bbb,not specified,126 days,1,,CMO:0000756,urine total protein excretion rate,,,,400,mg/d,,,MMO:0000426,Bradford protein assay,,0.0,,,,,controlled sodium content diet (3.7 mg/g) (for 84 days) and controlled sodium content drinking water (1 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days),84587,controlled sodium content diet (3.7 mg/g) (for 84 days),controlled sodium content drinking water (1 %) (for 84 days),controlled potassium content diet (6.3 mg/g) (for 84 days),,,, 2824,"Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b.",kidney mass,,RS:0000556,LH/Mav,male,119 days,7,,CMO:0000340,both kidneys wet weight to body weight ratio,,,,6.81,g/kg,0.19,0.5027,MMO:0000005,post excision weight measurement,,0.0,,,,,controlled sodium content drinking water (2 %) (for 8 days),103419,controlled sodium content drinking water (2 %) (for 8 days),,,,,, 2824,"Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b.",kidney mass,,RS:0000556,LH/Mav,male,119 days,8,,CMO:0000340,both kidneys wet weight to body weight ratio,,,,6.22,g/kg,0.21,0.594,MMO:0000005,post excision weight measurement,,0.0,,,,,perindopril (0.4 mg/kg/d) (for 63 days) then controlled sodium content drinking water (2 %) (for 8 days),103420,perindopril (0.4 mg/kg/d) (for 63 days),,,controlled sodium content drinking water (2 %) (for 8 days),,, 2824,"Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b.",kidney mass,,RS:0000556,LH/Mav,male,119 days,8,,CMO:0000340,both kidneys wet weight to body weight ratio,,,,5.87,g/kg,0.1,0.2828,MMO:0000005,post excision weight measurement,,0.0,,,,,perindopril (1.5 mg/kg/d) (for 63 days) then controlled sodium content drinking water (2 %) (for 8 days),103421,perindopril (1.5 mg/kg/d) (for 63 days),,,controlled sodium content drinking water (2 %) (for 8 days),,, 2824,"Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b.",kidney mass,,RS:0000556,LH/Mav,male,119 days,6,,CMO:0000340,both kidneys wet weight to body weight ratio,,,,7.22,g/kg,0.34,0.8328,MMO:0000005,post excision weight measurement,,0.0,,,,,controlled hydrochlorothiazide content drinking water (15 mg/kg/d) (for 63 days) and hydralazine (75 mg/kg/d) (for 63 days) then controlled sodium content drinking water (2 %) (for 8 days),103422,controlled hydrochlorothiazide content drinking water (15 mg/kg/d) (for 63 days),hydralazine (75 mg/kg/d) (for 63 days),,controlled sodium content drinking water (2 %) (for 8 days),,, 2824,"Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b.",kidney mass,,RS:0000556,LH/Mav,male,119 days,7,,CMO:0000340,both kidneys wet weight to body weight ratio,,,,7.3,g/kg,0.09,0.2381,MMO:0000005,post excision weight measurement,,0.0,,,,,controlled hydrochlorothiazide content drinking water (15 mg/kg/d) (for 63 days) and hydralazine (75 mg/kg/d) (for 63 days) and reserpine (0.75 mg/kg/d) (for 63 days) then controlled sodium content drinking water (2 %) (for 8 days),103423,controlled hydrochlorothiazide content drinking water (15 mg/kg/d) (for 63 days),hydralazine (75 mg/kg/d) (for 63 days),reserpine (0.75 mg/kg/d) (for 63 days),controlled sodium content drinking water (2 %) (for 8 days),,, 2824,"Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b.",heart left ventricle mass,,RS:0000556,LH/Mav,male,119 days,7,,CMO:0000530,heart left ventricle weight to body weight ratio,,,,2.48,mg/g,0.04,0.1058,MMO:0000005,post excision weight measurement,,0.0,,,,,controlled sodium content drinking water (2 %) (for 8 days),103409,controlled sodium content drinking water (2 %) (for 8 days),,,,,, 2824,"Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b.",heart left ventricle mass,,RS:0000556,LH/Mav,male,119 days,8,,CMO:0000530,heart left ventricle weight to body weight ratio,,,,2.41,mg/g,0.08,0.2263,MMO:0000005,post excision weight measurement,,0.0,,,,,perindopril (0.4 mg/kg/d) (for 63 days) then controlled sodium content drinking water (2 %) (for 8 days),103410,perindopril (0.4 mg/kg/d) (for 63 days),,,controlled sodium content drinking water (2 %) (for 8 days),,, 2824,"Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b.",heart left ventricle mass,,RS:0000556,LH/Mav,male,119 days,8,,CMO:0000530,heart left ventricle weight to body weight ratio,,,,2.37,mg/g,0.07,0.198,MMO:0000005,post excision weight measurement,,0.0,,,,,perindopril (1.5 mg/kg/d) (for 63 days) then controlled sodium content drinking water (2 %) (for 8 days),103411,perindopril (1.5 mg/kg/d) (for 63 days),,,controlled sodium content drinking water (2 %) (for 8 days),,, 2824,"Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b.",heart left ventricle mass,,RS:0000556,LH/Mav,male,119 days,6,,CMO:0000530,heart left ventricle weight to body weight ratio,,,,2.88,mg/g,0.06,0.147,MMO:0000005,post excision weight measurement,,0.0,,,,,controlled hydrochlorothiazide content drinking water (15 mg/kg/d) (for 63 days) and hydralazine (75 mg/kg/d) (for 63 days) then controlled sodium content drinking water (2 %) (for 8 days),103412,controlled hydrochlorothiazide content drinking water (15 mg/kg/d) (for 63 days),hydralazine (75 mg/kg/d) (for 63 days),,controlled sodium content drinking water (2 %) (for 8 days),,, 2824,"Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b.",heart left ventricle mass,,RS:0000556,LH/Mav,male,119 days,7,,CMO:0000530,heart left ventricle weight to body weight ratio,,,,2.79,mg/g,0.04,0.1058,MMO:0000005,post excision weight measurement,,0.0,,,,,controlled hydrochlorothiazide content drinking water (15 mg/kg/d) (for 63 days) and hydralazine (75 mg/kg/d) (for 63 days) and reserpine (0.75 mg/kg/d) (for 63 days) then controlled sodium content drinking water (2 %) (for 8 days),103413,controlled hydrochlorothiazide content drinking water (15 mg/kg/d) (for 63 days),hydralazine (75 mg/kg/d) (for 63 days),reserpine (0.75 mg/kg/d) (for 63 days),controlled sodium content drinking water (2 %) (for 8 days),,, 2824,"Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b.",aorta mass,,RS:0000556,LH/Mav,male,119 days,7,,CMO:0003216,aorta weight to body weight ratio,,,,13.3,mg/100g,0.6,1.5875,MMO:0000005,post excision weight measurement,,0.0,,,,,controlled sodium content drinking water (2 %) (for 8 days),103414,controlled sodium content drinking water (2 %) (for 8 days),,,,,, 2824,"Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b.",aorta mass,,RS:0000556,LH/Mav,male,119 days,8,,CMO:0003216,aorta weight to body weight ratio,,,,12.5,mg/100g,0.6,1.6971,MMO:0000005,post excision weight measurement,,0.0,,,,,perindopril (0.4 mg/kg/d) (for 63 days) then controlled sodium content drinking water (2 %) (for 8 days),103415,perindopril (0.4 mg/kg/d) (for 63 days),,,controlled sodium content drinking water (2 %) (for 8 days),,, 2824,"Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b.",aorta mass,,RS:0000556,LH/Mav,male,119 days,8,,CMO:0003216,aorta weight to body weight ratio,,,,13.6,mg/100g,0.5,1.4142,MMO:0000005,post excision weight measurement,,0.0,,,,,perindopril (1.5 mg/kg/d) (for 63 days) then controlled sodium content drinking water (2 %) (for 8 days),103416,perindopril (1.5 mg/kg/d) (for 63 days),,,controlled sodium content drinking water (2 %) (for 8 days),,, 2824,"Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b.",aorta mass,,RS:0000556,LH/Mav,male,119 days,6,,CMO:0003216,aorta weight to body weight ratio,,,,15.7,mg/100g,0.8,1.9596,MMO:0000005,post excision weight measurement,,0.0,,,,,controlled hydrochlorothiazide content drinking water (15 mg/kg/d) (for 63 days) and hydralazine (75 mg/kg/d) (for 63 days) then controlled sodium content drinking water (2 %) (for 8 days),103417,controlled hydrochlorothiazide content drinking water (15 mg/kg/d) (for 63 days),hydralazine (75 mg/kg/d) (for 63 days),,controlled sodium content drinking water (2 %) (for 8 days),,, 2824,"Naelten G, et al., J Cardiovasc Pharmacol. 2011 Feb;57(2):240-5. doi: 10.1097/FJC.0b013e318204bb7b.",aorta mass,,RS:0000556,LH/Mav,male,119 days,7,,CMO:0003216,aorta weight to body weight ratio,,,,15.8,mg/100g,0.8,2.1166,MMO:0000005,post excision weight measurement,,0.0,,,,,controlled hydrochlorothiazide content drinking water (15 mg/kg/d) (for 63 days) and hydralazine (75 mg/kg/d) (for 63 days) and reserpine (0.75 mg/kg/d) (for 63 days) then controlled sodium content drinking water (2 %) (for 8 days),103418,controlled hydrochlorothiazide content drinking water (15 mg/kg/d) (for 63 days),hydralazine (75 mg/kg/d) (for 63 days),reserpine (0.75 mg/kg/d) (for 63 days),controlled sodium content drinking water (2 %) (for 8 days),,, 3073,"Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012.",urine albumin amount,,RS:0002538,SHRSP/A3NCrl,male,148 days to 99 days,9,,CMO:0000757,urine albumin excretion rate,,8 week high salt high fat diet group,,282.4,mg/d,20.2,60.6,MMO:0000336,urine microalbumin analysis,,86400.0,8 week HSFD,,,,controlled sodium content drinking water (1 %) (for 56 days) and controlled fat content diet (24.5 %) (for 56 days),107060,controlled sodium content drinking water (1 %) (for 56 days),controlled fat content diet (24.5 %) (for 56 days),,,,, 3073,"Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012.",urine albumin amount,,RS:0002538,SHRSP/A3NCrl,male,148 days to 99 days,9,,CMO:0000757,urine albumin excretion rate,,8 week high salt high fat plus treatment,,142,mg/d,42.0,126.0,MMO:0000336,urine microalbumin analysis,,86400.0,8 week HSFD plus treatment,,,,controlled sodium content drinking water (1 %) (for 56 days) and controlled fat content diet (24.5 %) (for 56 days) then controlled BAY60-4552 content diet (3 mg/kg/d) (for 49 days),107061,controlled sodium content drinking water (1 %) (for 56 days),controlled fat content diet (24.5 %) (for 56 days),,controlled BAY60-4552 content diet (3 mg/kg/d) (for 49 days),,, 3073,"Costell MH, etal., Front Pharmacol. 2012 Jul 5;3:128. doi: 10.3389/fphar.2012.00128. eCollection 2012.",urine output,,RS:0002538,SHRSP/A3NCrl,male,148 days to 99 days,9,,CMO:0000260,timed urine volume,,8 week high salt high fat plus treatment,,79,ml/d,11.0,33.0,MMO:0000511,metabolic cage urine volume measurement method,,86400.0,8 week HSFD plus treatment,,,,controlled sodium content drinking water (1 %) (for 56 days) and controlled fat content diet (24.5 %) (for 56 days) then controlled BAY60-4552 content diet (0.3 mg/kg/d) (for 49 days),107055,controlled sodium content drinking water (1 %) (for 56 days),controlled fat content diet (24.5 %) (for 56 days),,controlled BAY60-4552 content diet (0.3 mg/kg/d) (for 49 days),,, 3035,"Rothermund L, et al., Eur J Pharmacol. 2003 May 16;468(3):209-16. doi: 10.1016/s0014-2999(03)01714-x.",kidney mass,,RS:0000679,SBN/Ygl,male,16 days,8,,CMO:0000340,both kidneys wet weight to body weight ratio,,n=8-15,,2.6,g/kg,0.05,0.1414,MMO:0000005,post excision weight measurement,,0.0,,,,,deoxycorticosterone acetate (75 mg) (for 56 days) and controlled sodium content drinking water (1 %) (for 56 days),106647,deoxycorticosterone acetate (75 mg) (for 56 days),controlled sodium content drinking water (1 %) (for 56 days),,,,, 3035,"Rothermund L, et al., Eur J Pharmacol. 2003 May 16;468(3):209-16. doi: 10.1016/s0014-2999(03)01714-x.",kidney mass,,RS:0000679,SBN/Ygl,male,16 days,8,,CMO:0000340,both kidneys wet weight to body weight ratio,,n=8-15,,2.7,g/kg,0.08,0.2263,MMO:0000005,post excision weight measurement,,0.0,,,,,deoxycorticosterone acetate (75 mg) (for 56 days) and controlled sodium content drinking water (1 %) (for 56 days) and darusentan (50 mg/kg/d) (for 56 days),106648,deoxycorticosterone acetate (75 mg) (for 56 days),controlled sodium content drinking water (1 %) (for 56 days),darusentan (50 mg/kg/d) (for 56 days),,,, 3035,"Rothermund L, et al., Eur J Pharmacol. 2003 May 16;468(3):209-16. doi: 10.1016/s0014-2999(03)01714-x.",kidney mass,,RS:0000677,SBH/Ygl,male,16 days,8,,CMO:0000340,both kidneys wet weight to body weight ratio,,n=8-15,,3,g/kg,0.08,0.2263,MMO:0000005,post excision weight measurement,,0.0,,,,,deoxycorticosterone acetate (75 mg) (for 56 days) and controlled sodium content drinking water (1 %) (for 56 days),106650,deoxycorticosterone acetate (75 mg) (for 56 days),controlled sodium content drinking water (1 %) (for 56 days),,,,, 3035,"Rothermund L, et al., Eur J Pharmacol. 2003 May 16;468(3):209-16. doi: 10.1016/s0014-2999(03)01714-x.",kidney mass,,RS:0000679,SBN/Ygl,male,16 days,8,,CMO:0000340,both kidneys wet weight to body weight ratio,,n=8-15,,3.2,g/kg,0.06,0.1697,MMO:0000005,post excision weight measurement,,0.0,,,,,deoxycorticosterone acetate (75 mg) (for 56 days) and controlled sodium content drinking water (1 %) (for 56 days) and darusentan (50 mg/kg/d) (for 56 days),106651,deoxycorticosterone acetate (75 mg) (for 56 days),controlled sodium content drinking water (1 %) (for 56 days),darusentan (50 mg/kg/d) (for 56 days),,,, 3035,"Rothermund L, et al., Eur J Pharmacol. 2003 May 16;468(3):209-16. doi: 10.1016/s0014-2999(03)01714-x.",body mass,,RS:0000679,SBN/Ygl,male,16 days,8,,CMO:0000012,body weight,,n=8-15,,319,g,5.0,14.1421,MMO:0000016,body weighing method,,0.0,,,,,deoxycorticosterone acetate (75 mg) (for 56 days) and controlled sodium content drinking water (1 %) (for 56 days),106641,deoxycorticosterone acetate (75 mg) (for 56 days),controlled sodium content drinking water (1 %) (for 56 days),,,,, 3035,"Rothermund L, et al., Eur J Pharmacol. 2003 May 16;468(3):209-16. doi: 10.1016/s0014-2999(03)01714-x.",body mass,,RS:0000679,SBN/Ygl,male,16 days,8,,CMO:0000012,body weight,,n=8-15,,345,g,6.9,19.5161,MMO:0000016,body weighing method,,0.0,,,,,deoxycorticosterone acetate (75 mg) (for 56 days) and controlled sodium content drinking water (1 %) (for 56 days) and darusentan (50 mg/kg/d) (for 56 days),106642,deoxycorticosterone acetate (75 mg) (for 56 days),controlled sodium content drinking water (1 %) (for 56 days),darusentan (50 mg/kg/d) (for 56 days),,,, 3035,"Rothermund L, et al., Eur J Pharmacol. 2003 May 16;468(3):209-16. doi: 10.1016/s0014-2999(03)01714-x.",body mass,,RS:0000677,SBH/Ygl,male,16 days,8,,CMO:0000012,body weight,,n=8-15,,340,g,8.9,25.173,MMO:0000016,body weighing method,,0.0,,,,,deoxycorticosterone acetate (75 mg) (for 56 days) and controlled sodium content drinking water (1 %) (for 56 days),106644,deoxycorticosterone acetate (75 mg) (for 56 days),controlled sodium content drinking water (1 %) (for 56 days),,,,, 3035,"Rothermund L, et al., Eur J Pharmacol. 2003 May 16;468(3):209-16. doi: 10.1016/s0014-2999(03)01714-x.",body mass,,RS:0000679,SBN/Ygl,male,16 days,8,,CMO:0000012,body weight,,n=8-15,,377,g,7.4,20.9304,MMO:0000016,body weighing method,,0.0,,,,,deoxycorticosterone acetate (75 mg) (for 56 days) and controlled sodium content drinking water (1 %) (for 56 days) and darusentan (50 mg/kg/d) (for 56 days),106645,deoxycorticosterone acetate (75 mg) (for 56 days),controlled sodium content drinking water (1 %) (for 56 days),darusentan (50 mg/kg/d) (for 56 days),,,, 3039,"Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006.",arterial blood pressure trait,,RS:0000677,SBH/Ygl,male,70 days,5,,CMO:0000004,systolic blood pressure,,,,195,mmHg,3.0,6.7082,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled exposure to a foster mother of a different strain within the same species. (for 30 days) then controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),106753,controlled exposure to a foster mother of a different strain within the same species. (for 30 days),,,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),, 3039,"Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006.",arterial blood pressure trait,,RS:0000677,SBH/Ygl,female,70 days,9,,CMO:0000004,systolic blood pressure,,,,196,mmHg,2.0,6.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled exposure to a foster mother of a different strain within the same species. (for 30 days) then controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),106755,controlled exposure to a foster mother of a different strain within the same species. (for 30 days),,,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),, 3039,"Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006.",arterial blood pressure trait,,RS:0000679,SBN/Ygl,male,70 days,12,,CMO:0000004,systolic blood pressure,,,,128,mmHg,1.0,3.4641,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled exposure to a foster mother of a different strain within the same species. (for 30 days) then controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),106749,controlled exposure to a foster mother of a different strain within the same species. (for 30 days),,,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),, 3039,"Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006.",arterial blood pressure trait,,RS:0000679,SBN/Ygl,female,70 days,16,,CMO:0000004,systolic blood pressure,,,,126,mmHg,1.0,4.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled exposure to a foster mother of a different strain within the same species. (for 30 days) then controlled sodium content drinking water (1 %) (for 28 days) and deoxycorticosterone acetate (25 mg) (for 28 days),106751,controlled exposure to a foster mother of a different strain within the same species. (for 30 days),,,controlled sodium content drinking water (1 %) (for 28 days),deoxycorticosterone acetate (25 mg) (for 28 days),, 3039,"Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006.",arterial blood pressure trait,,RS:0000677,SBH/Ygl,female,56 days to 52 days,5,,CMO:0000607,absolute change in systolic blood pressure,,"n=5-7, change between age 1month and 2 months",,56,mmHg,2.0,4.4721,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content drinking water (1 %) (for 30 days) and deoxycorticosterone acetate (25 mg) (for 30 days),106731,controlled sodium content drinking water (1 %) (for 30 days),deoxycorticosterone acetate (25 mg) (for 30 days),,,,, 3039,"Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006.",arterial blood pressure trait,,RS:0000677,SBH/Ygl,female,112 days to 108 days,5,,CMO:0000607,absolute change in systolic blood pressure,,"n=5-7, change between age 3months and 4 months",,55,mmHg,7.0,15.6525,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content drinking water (1 %) (between 24 and 28 days) and deoxycorticosterone acetate (75 mg) (for 90 days),106735,controlled sodium content drinking water (1 %) (between 24 and 28 days),deoxycorticosterone acetate (75 mg) (for 90 days),,,,, 3039,"Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006.",arterial blood pressure trait,,RS:0000677,SBH/Ygl,female,196 days to 192 days,5,,CMO:0000607,absolute change in systolic blood pressure,,"n=5-7, change between age 6 months and 7 months",,46,mmHg,4.0,8.9443,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content drinking water (1 %) (between 24 and 28 days) and deoxycorticosterone acetate (75 mg) (between 24 and 28 days) then deoxycorticosterone acetate (75 mg) (for 90 days),106739,controlled sodium content drinking water (1 %) (between 24 and 28 days),deoxycorticosterone acetate (75 mg) (between 24 and 28 days),,deoxycorticosterone acetate (75 mg) (for 90 days),,, 3039,"Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006.",arterial blood pressure trait,,RS:0000679,SBN/Ygl,male,280 days to 276 days,5,,CMO:0000607,absolute change in systolic blood pressure,,"n=5-7, change between age 9months and 10 months",,0,mmHg,1.0,2.2361,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content drinking water (1 %) (between 24 and 28 days) and deoxycorticosterone acetate (75 mg) (for 90 days) then deoxycorticosterone acetate (75 mg) (for 90 days) then deoxycorticosterone acetate (75 mg) (for 90 days),106740,controlled sodium content drinking water (1 %) (between 24 and 28 days),deoxycorticosterone acetate (75 mg) (for 90 days),,deoxycorticosterone acetate (75 mg) (for 90 days),,deoxycorticosterone acetate (75 mg) (for 90 days), 3039,"Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006.",arterial blood pressure trait,,RS:0000677,SBH/Ygl,female,364 days to 360 days,5,,CMO:0000607,absolute change in systolic blood pressure,,"n=5-7, change between age 12months and 13 months",,53,mmHg,1.0,2.2361,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content drinking water (1 %) (between 24 and 28 days) and deoxycorticosterone acetate (75 mg) (between 24 and 28 days) then deoxycorticosterone acetate (75 mg) (for 90 days) then deoxycorticosterone acetate (75 mg) (for 90 days) then deoxycorticosterone acetate (75 mg) (for 90 days),106747,controlled sodium content drinking water (1 %) (between 24 and 28 days),deoxycorticosterone acetate (75 mg) (between 24 and 28 days),,deoxycorticosterone acetate (75 mg) (for 90 days),,deoxycorticosterone acetate (75 mg) (for 90 days),deoxycorticosterone acetate (75 mg) (for 90 days) 3039,"Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006.",arterial blood pressure trait,,RS:0000679,SBN/Ygl,female,56 days to 52 days,5,,CMO:0000607,absolute change in systolic blood pressure,,"n=5-7, change between age 1month and 2 months",,6,mmHg,2.0,4.4721,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content drinking water (1 %) (for 30 days) and deoxycorticosterone acetate (25 mg) (for 30 days),106729,controlled sodium content drinking water (1 %) (for 30 days),deoxycorticosterone acetate (25 mg) (for 30 days),,,,, 3039,"Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006.",arterial blood pressure trait,,RS:0000677,SBH/Ygl,male,56 days to 52 days,5,,CMO:0000607,absolute change in systolic blood pressure,,"n=5-7, change between age 1month and 2 months",,52,mmHg,3.0,6.7082,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content drinking water (1 %) (for 30 days) and deoxycorticosterone acetate (25 mg) (for 30 days),106730,controlled sodium content drinking water (1 %) (for 30 days),deoxycorticosterone acetate (25 mg) (for 30 days),,,,, 3039,"Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006.",arterial blood pressure trait,,RS:0000679,SBN/Ygl,female,196 days to 192 days,5,,CMO:0000607,absolute change in systolic blood pressure,,"n=5-7, change between age 6 months and 7 months",,5,mmHg,2.0,4.4721,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content drinking water (1 %) (between 24 and 28 days) and deoxycorticosterone acetate (75 mg) (between 24 and 28 days) then deoxycorticosterone acetate (75 mg) (for 90 days),106737,controlled sodium content drinking water (1 %) (between 24 and 28 days),deoxycorticosterone acetate (75 mg) (between 24 and 28 days),,deoxycorticosterone acetate (75 mg) (for 90 days),,, 3039,"Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006.",arterial blood pressure trait,,RS:0000677,SBH/Ygl,male,196 days to 192 days,5,,CMO:0000607,absolute change in systolic blood pressure,,"n=5-7, change between age 6 months and 7 months",,54,mmHg,2.0,4.4721,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content drinking water (1 %) (between 24 and 28 days) and deoxycorticosterone acetate (75 mg) (between 24 and 28 days) then deoxycorticosterone acetate (75 mg) (for 90 days),106738,controlled sodium content drinking water (1 %) (between 24 and 28 days),deoxycorticosterone acetate (75 mg) (between 24 and 28 days),,deoxycorticosterone acetate (75 mg) (for 90 days),,, 3039,"Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006.",arterial blood pressure trait,,RS:0000677,SBH/Ygl,female,280 days to 276 days,5,,CMO:0000607,absolute change in systolic blood pressure,,"n=5-7, change between age 9months and 10 months",,51,mmHg,2.0,4.4721,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content drinking water (1 %) (between 24 and 28 days) and deoxycorticosterone acetate (75 mg) (for 90 days) then deoxycorticosterone acetate (75 mg) (for 90 days) then deoxycorticosterone acetate (75 mg) (for 90 days),106743,controlled sodium content drinking water (1 %) (between 24 and 28 days),deoxycorticosterone acetate (75 mg) (for 90 days),,deoxycorticosterone acetate (75 mg) (for 90 days),,deoxycorticosterone acetate (75 mg) (for 90 days), 3039,"Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006.",arterial blood pressure trait,,RS:0000679,SBN/Ygl,male,364 days to 360 days,5,,CMO:0000607,absolute change in systolic blood pressure,,"n=5-7, change between age 12months and 13 months",,0,mmHg,1.0,2.2361,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content drinking water (1 %) (between 24 and 28 days) and deoxycorticosterone acetate (75 mg) (between 24 and 28 days) then deoxycorticosterone acetate (75 mg) (for 90 days) then deoxycorticosterone acetate (75 mg) (for 90 days) then deoxycorticosterone acetate (75 mg) (for 90 days),106744,controlled sodium content drinking water (1 %) (between 24 and 28 days),deoxycorticosterone acetate (75 mg) (between 24 and 28 days),,deoxycorticosterone acetate (75 mg) (for 90 days),,deoxycorticosterone acetate (75 mg) (for 90 days),deoxycorticosterone acetate (75 mg) (for 90 days) 3039,"Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006.",arterial blood pressure trait,,RS:0000677,SBH/Ygl,male,364 days to 360 days,5,,CMO:0000607,absolute change in systolic blood pressure,,"n=5-7, change between age 12months and 13 months",,52,mmHg,3.0,6.7082,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content drinking water (1 %) (between 24 and 28 days) and deoxycorticosterone acetate (75 mg) (between 24 and 28 days) then deoxycorticosterone acetate (75 mg) (for 90 days) then deoxycorticosterone acetate (75 mg) (for 90 days) then deoxycorticosterone acetate (75 mg) (for 90 days),106746,controlled sodium content drinking water (1 %) (between 24 and 28 days),deoxycorticosterone acetate (75 mg) (between 24 and 28 days),,deoxycorticosterone acetate (75 mg) (for 90 days),,deoxycorticosterone acetate (75 mg) (for 90 days),deoxycorticosterone acetate (75 mg) (for 90 days) 3039,"Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006.",arterial blood pressure trait,,RS:0000679,SBN/Ygl,male,56 days to 52 days,5,,CMO:0000607,absolute change in systolic blood pressure,,"n=5-7, change between age 1month and 2 months",,2,mmHg,1.0,2.2361,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content drinking water (1 %) (for 30 days) and deoxycorticosterone acetate (25 mg) (for 30 days),106728,controlled sodium content drinking water (1 %) (for 30 days),deoxycorticosterone acetate (25 mg) (for 30 days),,,,, 3039,"Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006.",arterial blood pressure trait,,RS:0000679,SBN/Ygl,male,112 days to 108 days,5,,CMO:0000607,absolute change in systolic blood pressure,,"n=5-7, change between age 3months and 4 months",,2,mmHg,1.0,2.2361,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content drinking water (1 %) (between 24 and 28 days) and deoxycorticosterone acetate (75 mg) (for 90 days),106732,controlled sodium content drinking water (1 %) (between 24 and 28 days),deoxycorticosterone acetate (75 mg) (for 90 days),,,,, 3039,"Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006.",arterial blood pressure trait,,RS:0000679,SBN/Ygl,female,112 days to 108 days,5,,CMO:0000607,absolute change in systolic blood pressure,,"n=5-7, change between age 3months and 4 months",,4,mmHg,1.0,2.2361,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content drinking water (1 %) (between 24 and 28 days) and deoxycorticosterone acetate (75 mg) (for 90 days),106733,controlled sodium content drinking water (1 %) (between 24 and 28 days),deoxycorticosterone acetate (75 mg) (for 90 days),,,,, 3039,"Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006.",arterial blood pressure trait,,RS:0000677,SBH/Ygl,male,112 days to 108 days,5,,CMO:0000607,absolute change in systolic blood pressure,,"n=5-7, change between age 3months and 4 months",,58,mmHg,4.0,8.9443,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content drinking water (1 %) (between 24 and 28 days) and deoxycorticosterone acetate (75 mg) (for 90 days),106734,controlled sodium content drinking water (1 %) (between 24 and 28 days),deoxycorticosterone acetate (75 mg) (for 90 days),,,,, 3039,"Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006.",arterial blood pressure trait,,RS:0000679,SBN/Ygl,male,196 days to 192 days,5,,CMO:0000607,absolute change in systolic blood pressure,,"n=5-7, change between age 6 months and 7 months",,1,mmHg,1.0,2.2361,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content drinking water (1 %) (between 24 and 28 days) and deoxycorticosterone acetate (75 mg) (for 90 days) then deoxycorticosterone acetate (75 mg) (for 90 days),106736,controlled sodium content drinking water (1 %) (between 24 and 28 days),deoxycorticosterone acetate (75 mg) (for 90 days),,deoxycorticosterone acetate (75 mg) (for 90 days),,, 3039,"Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006.",arterial blood pressure trait,,RS:0000679,SBN/Ygl,female,280 days to 276 days,5,,CMO:0000607,absolute change in systolic blood pressure,,"n=5-7, change between age 9months and 10 months",,-3,mmHg,1.0,2.2361,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content drinking water (1 %) (between 24 and 28 days) and deoxycorticosterone acetate (75 mg) (for 90 days) then deoxycorticosterone acetate (75 mg) (for 90 days) then deoxycorticosterone acetate (75 mg) (for 90 days),106741,controlled sodium content drinking water (1 %) (between 24 and 28 days),deoxycorticosterone acetate (75 mg) (for 90 days),,deoxycorticosterone acetate (75 mg) (for 90 days),,deoxycorticosterone acetate (75 mg) (for 90 days), 3039,"Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006.",arterial blood pressure trait,,RS:0000677,SBH/Ygl,male,280 days to 276 days,5,,CMO:0000607,absolute change in systolic blood pressure,,"n=5-7, change between age 9months and 10 months",,49,mmHg,2.0,4.4721,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content drinking water (1 %) (between 24 and 28 days) and deoxycorticosterone acetate (75 mg) (for 90 days) then deoxycorticosterone acetate (75 mg) (for 90 days) then deoxycorticosterone acetate (75 mg) (for 90 days),106742,controlled sodium content drinking water (1 %) (between 24 and 28 days),deoxycorticosterone acetate (75 mg) (for 90 days),,deoxycorticosterone acetate (75 mg) (for 90 days),,deoxycorticosterone acetate (75 mg) (for 90 days), 3039,"Yagil Y and Yagil C, J Hypertens. 2000 Oct;18(10):1393-9. doi: 10.1097/00004872-200018100-00006.",arterial blood pressure trait,,RS:0000679,SBN/Ygl,female,364 days to 360 days,5,,CMO:0000607,absolute change in systolic blood pressure,,"n=5-7, change between age 12months and 13 months",,2,mmHg,1.0,2.2361,MMO:0000031,tail cuff plethysmography,,0.0,,,,,controlled sodium content drinking water (1 %) (between 24 and 28 days) and deoxycorticosterone acetate (75 mg) (between 24 and 28 days) then deoxycorticosterone acetate (75 mg) (for 90 days) then deoxycorticosterone acetate (75 mg) (for 90 days) then deoxycorticosterone acetate (75 mg) (for 90 days),106745,controlled sodium content drinking water (1 %) (between 24 and 28 days),deoxycorticosterone acetate (75 mg) (between 24 and 28 days),,deoxycorticosterone acetate (75 mg) (for 90 days),,deoxycorticosterone acetate (75 mg) (for 90 days),deoxycorticosterone acetate (75 mg) (for 90 days) 3100,"Willette RN, etal., J Cardiovasc Pharmacol. 2001 Oct;38(4):606-17. doi: 10.1097/00005344-200110000-00013.",blood aldosterone amount,,RS:0000775,SHRSP/A3N,male,210 days to 182 days,8,,CMO:0000551,plasma aldosterone level,,,,347,pg/ml,72.0,203.6468,MMO:0000073,radioimmunoassay,,0.0,,,,,controlled sodium content drinking water (1 %) (for 112 days) and controlled fat content diet (24.5 %) (for 112 days),107938,controlled sodium content drinking water (1 %) (for 112 days),controlled fat content diet (24.5 %) (for 112 days),,,,, 3075,"Barone FC, etal., Pharmacology. 2007;80(2-3):166-76. doi: 10.1159/000103384. Epub 2007 Jun 4.",heart pumping trait,,RS:0000775,SHRSP/A3N,male,210 days to 189 days,N/A,,CMO:0000002,heart rate,,high salt high fat diet +carvedilol,,254,beats/min,10.0,,MMO:0000002,transthoracic echocardiography,,0.0,,,,,controlled sodium content drinking water (1 %) (between 112 and 126 days) and controlled fat content diet (24.5 %) (between 112 and 126 days) and controlled carvedilol content diet (2400 ppm) (between 112 and 126 days),107129,controlled sodium content drinking water (1 %) (between 112 and 126 days),controlled fat content diet (24.5 %) (between 112 and 126 days),controlled carvedilol content diet (2400 ppm) (between 112 and 126 days),,,, 3075,"Barone FC, etal., Pharmacology. 2007;80(2-3):166-76. doi: 10.1159/000103384. Epub 2007 Jun 4.",heart pumping trait,,RS:0000775,SHRSP/A3N,male,210 days to 189 days,N/A,,CMO:0000002,heart rate,,high salt high fat diet,,277,beats/min,6.0,,MMO:0000002,transthoracic echocardiography,,0.0,,,,,controlled sodium content drinking water (1 %) (between 112 and 126 days) and controlled fat content diet (24.5 %) (between 112 and 126 days),107130,controlled sodium content drinking water (1 %) (between 112 and 126 days),controlled fat content diet (24.5 %) (between 112 and 126 days),,,,, 3075,"Barone FC, etal., Pharmacology. 2007;80(2-3):166-76. doi: 10.1159/000103384. Epub 2007 Jun 4.",body mass,,RS:0000775,SHRSP/A3N,male,224 days to 203 days,10,,CMO:0000012,body weight,,high salt high fat diet +carvedilol,,367,g,10.0,31.6228,MMO:0000016,body weighing method,,0.0,,,,,controlled sodium content drinking water (1 %) (for 126 days) and controlled fat content diet (24.5 %) (for 126 days) and controlled carvedilol content diet (2400 ppm) (for 126 days),107103,controlled sodium content drinking water (1 %) (for 126 days),controlled fat content diet (24.5 %) (for 126 days),controlled carvedilol content diet (2400 ppm) (for 126 days),,,, 3075,"Barone FC, etal., Pharmacology. 2007;80(2-3):166-76. doi: 10.1159/000103384. Epub 2007 Jun 4.",cardiac output trait,,RS:0000775,SHRSP/A3N,male,210 days to 189 days,N/A,,CMO:0000181,end-systolic volume,,high salt high fat diet +carvedilol,,0.28,ml,0.03,,MMO:0000002,transthoracic echocardiography,,0.0,,,,,controlled sodium content drinking water (1 %) (between 112 and 126 days) and controlled fat content diet (24.5 %) (between 112 and 126 days) and controlled carvedilol content diet (2400 ppm) (between 112 and 126 days),107125,controlled sodium content drinking water (1 %) (between 112 and 126 days),controlled fat content diet (24.5 %) (between 112 and 126 days),controlled carvedilol content diet (2400 ppm) (between 112 and 126 days),,,, 3075,"Barone FC, etal., Pharmacology. 2007;80(2-3):166-76. doi: 10.1159/000103384. Epub 2007 Jun 4.",cardiac output trait,,RS:0000775,SHRSP/A3N,male,210 days to 189 days,N/A,,CMO:0000181,end-systolic volume,,high salt high fat diet,,0.29,ml,0.04,,MMO:0000002,transthoracic echocardiography,,0.0,,,,,controlled sodium content drinking water (1 %) (between 112 and 126 days) and controlled fat content diet (24.5 %) (between 112 and 126 days),107126,controlled sodium content drinking water (1 %) (between 112 and 126 days),controlled fat content diet (24.5 %) (between 112 and 126 days),,,,, 3075,"Barone FC, etal., Pharmacology. 2007;80(2-3):166-76. doi: 10.1159/000103384. Epub 2007 Jun 4.",cardiac output trait,,RS:0000775,SHRSP/A3N,male,210 days to 189 days,N/A,,CMO:0000221,end-diastolic volume,,high salt high fat diet +carvedilol,,0.96,ml,0.02,,MMO:0000002,transthoracic echocardiography,,0.0,,,,,controlled sodium content drinking water (1 %) (between 112 and 126 days) and controlled fat content diet (24.5 %) (between 112 and 126 days) and controlled carvedilol content diet (2400 ppm) (between 112 and 126 days),107121,controlled sodium content drinking water (1 %) (between 112 and 126 days),controlled fat content diet (24.5 %) (between 112 and 126 days),controlled carvedilol content diet (2400 ppm) (between 112 and 126 days),,,, 3075,"Barone FC, etal., Pharmacology. 2007;80(2-3):166-76. doi: 10.1159/000103384. Epub 2007 Jun 4.",cardiac output trait,,RS:0000775,SHRSP/A3N,male,210 days to 189 days,N/A,,CMO:0000221,end-diastolic volume,,high salt high fat diet,,0.69,ml,0.05,,MMO:0000002,transthoracic echocardiography,,0.0,,,,,controlled sodium content drinking water (1 %) (between 112 and 126 days) and controlled fat content diet (24.5 %) (between 112 and 126 days),107122,controlled sodium content drinking water (1 %) (between 112 and 126 days),controlled fat content diet (24.5 %) (between 112 and 126 days),,,,, 3088,"Wong VY, etal., Br J Pharmacol. 2001 Nov;134(5):977-84. doi: 10.1038/sj.bjp.0704329.",urine protein amount,,RS:0000775,SHRSP/A3N,male,224 days to 210 days,N/A,,CMO:0000756,urine total protein excretion rate,,,,251,mg/d,120.0,,MMO:0000334,urine protein analysis,,86400.0,metabolic cage; sulfosalicylic acid method,,,,controlled sodium content drinking water (1 %) (for 126 days) and controlled fat content diet (24.5 %) (for 126 days),107473,controlled sodium content drinking water (1 %) (for 126 days),controlled fat content diet (24.5 %) (for 126 days),,,,, 3088,"Wong VY, etal., Br J Pharmacol. 2001 Nov;134(5):977-84. doi: 10.1038/sj.bjp.0704329.",urine protein amount,,RS:0000775,SHRSP/A3N,male,224 days to 210 days,N/A,,CMO:0000756,urine total protein excretion rate,,,,37,mg/d,15.0,,MMO:0000334,urine protein analysis,,86400.0,metabolic cage; sulfosalicylic acid method,,,,controlled sodium content drinking water (1 %) (for 126 days) and controlled fat content diet (24.5 %) (for 126 days) and controlled carvedilol content diet (2400 ppm) (for 126 days),107474,controlled sodium content drinking water (1 %) (for 126 days),controlled fat content diet (24.5 %) (for 126 days),controlled carvedilol content diet (2400 ppm) (for 126 days),,,, 3088,"Wong VY, etal., Br J Pharmacol. 2001 Nov;134(5):977-84. doi: 10.1038/sj.bjp.0704329.",kidney integrity trait,,RS:0000775,SHRSP/A3N,male,224 days to 210 days,N/A,,CMO:0003443,kidney tubule regeneration foci count,,foci of tubular regeneration,,6.4,/section,1.0,,MMO:0000561,ex vivo light microscopy with histochemistry,,0.0,,,,,controlled sodium content drinking water (1 %) (for 126 days) and controlled fat content diet (24.5 %) (for 126 days),107485,controlled sodium content drinking water (1 %) (for 126 days),controlled fat content diet (24.5 %) (for 126 days),,,,, 3088,"Wong VY, etal., Br J Pharmacol. 2001 Nov;134(5):977-84. doi: 10.1038/sj.bjp.0704329.",kidney integrity trait,,RS:0000775,SHRSP/A3N,male,224 days to 210 days,N/A,,CMO:0003443,kidney tubule regeneration foci count,,foci of tubular regeneration,,1.9,/section,1.3,,MMO:0000561,ex vivo light microscopy with histochemistry,,0.0,,,,,controlled sodium content drinking water (1 %) (for 126 days) and controlled fat content diet (24.5 %) (for 126 days) and controlled carvedilol content diet (2400 ppm) (for 126 days),107486,controlled sodium content drinking water (1 %) (for 126 days),controlled fat content diet (24.5 %) (for 126 days),controlled carvedilol content diet (2400 ppm) (for 126 days),,,, 3088,"Wong VY, etal., Br J Pharmacol. 2001 Nov;134(5):977-84. doi: 10.1038/sj.bjp.0704329.",kidney integrity trait,,RS:0000775,SHRSP/A3N,male,224 days to 210 days,N/A,,CMO:0003445,interstitial nephritis foci count,,foci of interstitial nephritis,,6.6,/section,2.3,,MMO:0000561,ex vivo light microscopy with histochemistry,,0.0,,,,,controlled sodium content drinking water (1 %) (for 126 days) and controlled fat content diet (24.5 %) (for 126 days),107489,controlled sodium content drinking water (1 %) (for 126 days),controlled fat content diet (24.5 %) (for 126 days),,,,, 3088,"Wong VY, etal., Br J Pharmacol. 2001 Nov;134(5):977-84. doi: 10.1038/sj.bjp.0704329.",kidney integrity trait,,RS:0000775,SHRSP/A3N,male,224 days to 210 days,N/A,,CMO:0003445,interstitial nephritis foci count,,foci of interstitial nephritis,,2.4,/section,0.8,,MMO:0000561,ex vivo light microscopy with histochemistry,,0.0,,,,,controlled sodium content drinking water (1 %) (for 126 days) and controlled fat content diet (24.5 %) (for 126 days) and controlled carvedilol content diet (2400 ppm) (for 126 days),107490,controlled sodium content drinking water (1 %) (for 126 days),controlled fat content diet (24.5 %) (for 126 days),controlled carvedilol content diet (2400 ppm) (for 126 days),,,, 3088,"Wong VY, etal., Br J Pharmacol. 2001 Nov;134(5):977-84. doi: 10.1038/sj.bjp.0704329.",kidney integrity trait,,RS:0000775,SHRSP/A3N,male,224 days to 210 days,N/A,,CMO:0003444,kidney total tubule cast count,,total tubular casts,,350,/section,80.0,,MMO:0000561,ex vivo light microscopy with histochemistry,,0.0,,,,,controlled sodium content drinking water (1 %) (for 126 days) and controlled fat content diet (24.5 %) (for 126 days),107493,controlled sodium content drinking water (1 %) (for 126 days),controlled fat content diet (24.5 %) (for 126 days),,,,, 3088,"Wong VY, etal., Br J Pharmacol. 2001 Nov;134(5):977-84. doi: 10.1038/sj.bjp.0704329.",kidney integrity trait,,RS:0000775,SHRSP/A3N,male,224 days to 210 days,N/A,,CMO:0003444,kidney total tubule cast count,,total tubular casts,,21,/section,11.0,,MMO:0000561,ex vivo light microscopy with histochemistry,,0.0,,,,,controlled sodium content drinking water (1 %) (for 126 days) and controlled fat content diet (24.5 %) (for 126 days) and controlled carvedilol content diet (2400 ppm) (for 126 days),107494,controlled sodium content drinking water (1 %) (for 126 days),controlled fat content diet (24.5 %) (for 126 days),controlled carvedilol content diet (2400 ppm) (for 126 days),,,, 3088,"Wong VY, etal., Br J Pharmacol. 2001 Nov;134(5):977-84. doi: 10.1038/sj.bjp.0704329.",kidney integrity trait,,RS:0000775,SHRSP/A3N,male,224 days to 210 days,N/A,,CMO:0003446,renal fibrosis foci count,,foci of renal fibrosis,,25,/section,1.0,,MMO:0000561,ex vivo light microscopy with histochemistry,,0.0,,,,,controlled sodium content drinking water (1 %) (for 126 days) and controlled fat content diet (24.5 %) (for 126 days),107497,controlled sodium content drinking water (1 %) (for 126 days),controlled fat content diet (24.5 %) (for 126 days),,,,, 3088,"Wong VY, etal., Br J Pharmacol. 2001 Nov;134(5):977-84. doi: 10.1038/sj.bjp.0704329.",kidney integrity trait,,RS:0000775,SHRSP/A3N,male,224 days to 210 days,N/A,,CMO:0003446,renal fibrosis foci count,,foci of renal fibrosis,,15,/section,2.0,,MMO:0000561,ex vivo light microscopy with histochemistry,,0.0,,,,,controlled sodium content drinking water (1 %) (for 126 days) and controlled fat content diet (24.5 %) (for 126 days) and controlled carvedilol content diet (2400 ppm) (for 126 days),107498,controlled sodium content drinking water (1 %) (for 126 days),controlled fat content diet (24.5 %) (for 126 days),controlled carvedilol content diet (2400 ppm) (for 126 days),,,, 3088,"Wong VY, etal., Br J Pharmacol. 2001 Nov;134(5):977-84. doi: 10.1038/sj.bjp.0704329.",kidney glomerulus integrity trait,,RS:0000775,SHRSP/A3N,male,224 days to 210 days,N/A,,CMO:0003447,kidney glomerular lesion count,,,,31,/section,5.0,,MMO:0000561,ex vivo light microscopy with histochemistry,,0.0,,,,,controlled sodium content drinking water (1 %) (for 126 days) and controlled fat content diet (24.5 %) (for 126 days),107477,controlled sodium content drinking water (1 %) (for 126 days),controlled fat content diet (24.5 %) (for 126 days),,,,, 3088,"Wong VY, etal., Br J Pharmacol. 2001 Nov;134(5):977-84. doi: 10.1038/sj.bjp.0704329.",kidney glomerulus integrity trait,,RS:0000775,SHRSP/A3N,male,224 days to 210 days,N/A,,CMO:0003447,kidney glomerular lesion count,,,,4,/section,2.0,,MMO:0000561,ex vivo light microscopy with histochemistry,,0.0,,,,,controlled sodium content drinking water (1 %) (for 126 days) and controlled fat content diet (24.5 %) (for 126 days) and controlled carvedilol content diet (2400 ppm) (for 126 days),107478,controlled sodium content drinking water (1 %) (for 126 days),controlled fat content diet (24.5 %) (for 126 days),controlled carvedilol content diet (2400 ppm) (for 126 days),,,,